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ABSTRACT 
 
DEFINING INTERACTIONS BETWEEN LYMPHOID TISSUE-RESIDENT 
COMMENSAL BACTERIA AND THE HOST IMMUNE SYSTEM 
 
Thomas Chia Ting Fung 
 
Gregory F. Sonnenberg 
David Artis 
 
The mammalian gastro-intestinal tract is colonized by trillions of beneficial 
commensal bacteria that are essential for promoting normal host physiology. 
While the majority of commensal bacteria are found in the intestinal lumen, many 
species have also adapted to colonize different anatomical locations in the 
intestine including the surface of intestinal epithelial cells (IECs) and the interior 
of gut-associated lymphoid tissues. Distinct tissue localization of commensal 
bacteria permits unique interactions between these microbes and the mammalian 
immune system and collectively influences intestinal immune cell homeostasis. 
Conversely, dysregulated localization of commensal bacteria can lead to 
inappropriate activation of the immune system and is associated with numerous 
chronic infectious, inflammatory and metabolic diseases. Therefore, regulatory 
mechanisms that control proper anatomical containment of commensal bacteria 
 v 
are essential to maintain tissue homeostasis and limit pathology. Although the 
roles of luminal and epithelial-associated commensal bacteria on immune cell 
homeostasis have been extensively studied, how lymphoid tissue-resident 
commensals (LRC) modulate host immune responses is not well understood. 
Data in Chapter 2 will describe interactions between a genetically related family 
of LRCs that can colonize dendritic cells and induces lymphoid tissue-specific 
immune responses. Further, Chapter 3 will provide evidence that LRC-induced 
immune responses are mutually beneficial for itself and the host. Specifically, 
LRC-induced interleukin (IL)-22 enhances its own microbial colonization and 
LRC-induced IL-10 limits tissue inflammation during intestinal injury.  
Dysregulated anatomical localization of commensal bacteria during 
chronic inflammatory conditions is typically associated with extra-intestinal 
complications including anemia or dysregulated iron homeostasis. Results in 
Chapter 4 support a role for the iron-regulatory hormone hepcidin in modulating 
LRC colonization of DCs and identify hepcidin as a critical regulator of immune 
cell homeostasis and tissue repair following intestinal injury. Collectively, studies 
presented in this thesis define mutually beneficial interactions between 
mammalian hosts and commensal bacteria in intestinal-associated lymphoid 
tissues that regulate immune cell homeostasis and host responses to tissue 
inflammation or injury. 
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Chapter 1 
Introduction 
 
Trillions of commensal microorganisms collectively termed the microbiota 
colonize the mammalian gastrointestinal tract (GI). Most of these microbes 
belong to three bacteria phyla: Bacteroidetes, Firmicutes and Proteobacteria. 
Recent work has demonstrated a critical role for commensal bacteria in host 
nutrient metabolism, colonization resistance against invading pathogens and 
development and maturation of the immune system. Maintenance of proper host-
commensal interactions is essential for host health as dysregulated interactions 
are often associated with and contribute to chronic inflammatory diseases. 
Despite recent findings describing the molecular and cellular mechanisms that 
promote healthy host-commensal bacteria interactions, our understanding of 1) 
the anatomical localization of commensal bacteria in health and disease, 2) the 
role of distinct commensal bacteria communities on immune cell homeostasis 
and 3) the functional consequences of commensal bacteria colonization for the 
host, is incomplete and requires further investigation.  
Most commensal bacteria in mammalian hosts are found in the lumen of 
the GI tract and are physically separated from the intestinal epithelium. However, 
some bacteria are able to bypass this physical barrier to colonize the surface of 
intestinal epithelial cells (IECs). More recently, commensal bacteria signatures 
were detected in the interior of intestinal-associated lymphoid tissues such as 
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Peyer’s patches and the mesenteric lymph node, suggesting that commensals 
colonize these immune cell-rich sites previously thought to be devoid of bacteria. 
Based on these findings, commensal bacteria can be classified by their 
anatomical localization as i) luminal, ii) epithelial-associated or iii) lymphoid 
tissue-resident. Most studies in the past decade have focused on how the host 
pathways recognize and interact with luminal and epithelial-associated 
commensal bacteria. However, much less is known about how lymphoid tissue-
resident commensal bacteria (LRC) colonize and interact with the host. The aim 
of this thesis is to comprehensively investigate and define interactions between 
LRCs and the host immune system. This Chapter will introduce our current 
understanding of intestinal commensal bacteria anatomical localization in the 
context of a healthy mammalian GI tract and during chronic inflammation. The 
end of this Chapter will also introduce the role of iron homeostasis in host-
microbe interactions and immune cell function. Chapter 2 will highlight the 
cellular mechanisms by which LRCs gain access to and colonize intestinal-
associated lymphoid tissues and characterize the immunological consequences 
of LRC colonization. Further, Chapter 3 will investigate the role of LRC-induced 
immune pathways on commensal bacteria colonization and tissue protection 
during intestinal injury. Finally, Chapter 4 will explore the role of iron 
homeostasis and the iron-regulatory hormone hepcidin in LRC colonization and 
immune cell homeostasis. 
 
 3 
1.1 Anatomical localization of intestinal commensal bacteria in the healthy 
mammalian GI tract  
The mammalian GI tract is colonized by trillions of beneficial microbes including 
bacteria, fungi and viruses, which collectively influence host intestinal physiology. 
Levels of commensal bacteria in the GI tract have been reported to be as high as 
1014 organisms, with over 1000 different bacterial species represented (Backhed 
et al., 2005; Ley et al., 2008; Ley et al., 2006; Turnbaugh et al., 2007; Xu et al., 
2007). Some of the most well characterized roles of commensal bacteria include 
promoting efficient host nutrient absorption and protection from pathogen 
colonization (Brestoff and Artis, 2013; Buffie and Pamer, 2013; Cani, 2014; Flint 
et al., 2012; Kamada et al., 2013a; Musso et al., 2011). In addition, an expanding 
body of literature has identified critical roles for commensal bacteria in the 
development of the host immune system and maintenance of immune cell 
homeostasis (Hooper et al., 2012; Ivanov and Honda, 2012).  
In contrast to the ability of commensal bacteria to confer host-beneficial 
properties, dysregulated interactions between commensal bacteria and the host 
are associated with many chronic infectious, inflammatory and metabolic 
diseases such as inflammatory bowel disease (IBD), chronic viral infection, 
obesity, cancer and cardiovascular disease (Hooper et al., 2012; Kamada et al., 
2013b). Progression of disease in these settings has been proposed to occur 
either by changes in the composition of the microbiota known as dysbiosis and/or 
bacterial translocation (Blumberg and Powrie, 2012; Brenchley and Douek, 2012; 
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Brenchley et al., 2006; Henao-Mejia et al., 2012; Hooper et al., 2012; Kamada et 
al., 2013b; Loh and Blaut, 2012; Manichanh et al., 2012; Wang et al., 2011). 
Although many studies have identified and characterized dysbiosis during 
disease, much less is known about the role of commensal bacteria localization in 
disease development and pathogenesis.  
The majority of our current knowledge on the role of the microbiota in 
health and disease is derived from studies describing luminal commensal 
bacteria. However, emerging studies suggest that, in the steady state, specific 
commensal populations colonize distinct compartments of the intestine and 
selectively alter immune cell homeostasis to provide host tissue protection. For 
example, the Firmicutes phylum member Clostridium spp. was demonstrated to 
colonize the lumen of the colon while the Bacteroidetes phylum member 
Bacteroides fragilis was shown to colonize both the lumen and crypts of the colon 
(Atarashi et al., 2013; Atarashi et al., 2011; Lee et al., 2013; Round et al., 2011; 
Round and Mazmanian, 2010). In contrast, the gram-positive segmented 
filamentous bacteria (SFB) colonize the intestine by adhering tightly to epithelial 
cells of the terminal ileum in mice (Gaboriau-Routhiau et al., 2009; Ivanov et al., 
2009). These studies highlight that the anatomical localization of commensal 
bacteria in the intestine can be categorized into at least two groups: (i) luminal 
and (ii) epithelial-associated. More recently, additional studies have described 
gut-associated lymphoid tissues as a novel and unexpected site for commensal 
bacterial colonization in healthy mammals. These commensal species, herein 
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referred to as lymphoid tissue-resident commensal bacteria (LRC), were shown 
to colonize the interior of Peyer’s patches (PPs) of healthy mice, primates and 
humans (Kunisawa and Kiyono, 2012; Obata et al., 2010; Sato et al., 2013; 
Sonnenberg et al., 2012). Despite our growing understanding of host-commensal 
bacteria relationships, how these interactions are influenced by commensal 
bacteria colonization in different compartments of the intestine is not well 
understood. This Chapter will discuss how anatomically distinct commensal 
populations, including (i) luminal, (ii) epithelial-associated or (iii) lymphoid tissue-
resident (Figure 1), are recognized by the immune system, influence immune cell 
function and are anatomically restricted via host and bacterial intrinsic 
mechanisms. Furthermore, this Chapter will review current literature on how 
dysregulated commensal bacteria localization in mice and humans may 
contribute to a variety of chronic inflammatory diseases.  
 
1.1.1 Luminal commensal bacteria  
Analyses of commensal bacteria composition in the mammalian GI tract have 
mainly focused on 16S rDNA sequencing of luminal contents from the intestine. 
In healthy mice, luminal commensal bacteria are largely represented by three 
phyla: Bacteroidetes, Firmicutes and Proteobacteria. Within these groups, 
approximately 70% are Bacteroidetes, 20% are Firmicutes and less than 2% are 
Proteobacteria (Eckburg et al., 2005; Hill et al., 2010; Ley et al., 2005; Ley et al., 
2006). Consistent with the intestine being a hypoxic environment, most luminal 
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commensal bacteria, especially Bacteroidetes and Firmicutes members, are 
obligate anaerobes (Colgan and Taylor, 2010; Glover and Colgan, 2011). 
Furthermore, many of these bacteria are not culturable using current techniques 
and have only been identified through 16S rDNA sequencing (2012; Salzman et 
al., 2002). Using this technique to interrogate interactions between the host and 
luminal commensal bacteria, an increasing body of data has revealed that 
members of both Bacteroidetes and Firmicutes have profound roles in shaping 
the host immune system.  
The Bacteroidetes phylum is comprised predominantly of gram-negative, 
rod-shaped, anaerobic bacteria. Within this phylum, the genus Bacteroides is 
highly represented along the mammalian GI tract and has been reported to reach 
as high as 1010 – 1011 organisms per gram of human feces (Wexler, 2007). Many 
members of the Bacteroides genus including B. thetaiotaomicron and B. fragilis 
are well adapted to thrive in the GI tract (Wexler, 2007) and have been described 
to aid in host metabolism by processing complex polysaccharides into smaller 
compounds for host absorption (Comstock, 2009). Studies interrogating the 
interactions between Bacteroides and the host immune system have focused 
primarily on one species, B. fragilis (Figure 2). An identifying feature of this 
bacterium is the presence of a capsular polysaccharide complex composed of 
eight capsular polysaccharides, of which polysaccharide A (PSA) is the most 
highly expressed (Surana and Kasper, 2012). While PSA can elicit pro-
inflammatory responses such as production of interleukin (IL)-12, tumor necrosis 
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factor alpha (TNFα) and interferon gamma (IFNγ) through recognition by 
dendritic cells (DCs) (Surana and Kasper, 2012), it also has potent anti-
inflammatory properties and can stimulate interleukin (IL)-10-producing CD4+ 
Foxp3+ Tregs in the colon (Round and Mazmanian, 2010). Surprisingly, this 
response was independent of antigen presenting cells (APCs) but dependent on 
T cell recognition of PSA by Toll-like receptor (TLR) 2 (Round et al., 2011). In 
mice, this immunomodulatory response was required for intestinal colonization by 
B. fragilis and was associated with protection from experimental colitis (Round 
and Mazmanian, 2010). B. fragilis could also produce glycosphingolipids that 
inhibit invariant natural killer T (iNKT) cell proliferation, likely by interfering with 
lipid loading on CD1d molecules (An et al., 2014). Functionally, modulation of 
iNKT cell homeostasis in the colon by B. fragilis glycosphingolipids protected 
mice from iNKT cell-mediated intestinal inflammation. In a separate report, it was 
demonstrated that B. fragilis could produce immunostimulatory glycolipids that 
bind CD1d and activate iNKT cells in mice and humans (Wieland Brown et al., 
2013), suggesting a dual role for Bacteroides glycolipids in regulating immune 
cell homeostasis.  
Patients with autism spectrum disorder (ASD) often present with GI 
symptoms (Adams et al., 2011; Buie et al., 2010; Coury et al., 2012; Kohane et 
al., 2012). In recent findings, B. fragilis was demonstrated to correct behavioral 
abnormalities and restore increased intestinal permeability and altered luminal 
commensal bacteria composition in a mouse model of ASD (Hsiao et al., 2013). 
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Notably, oral treatment with PSA-deficient B. fragilis or wild-type B. 
thetaiotaomicron but not Enterococcus faecalis also improved anxiety-like, 
repetitive and communicative behavior of mice with ASD, suggesting that host 
protection by Bacteroides is not specific to B. fragilis. Furthermore, it was 
demonstrated that oral treatment of ASD mice with B. fragilis could limit elevated 
levels of the neurotoxic, commensal bacteria-derived serum metabolite 4-
ethylphenylsulfate. These findings suggest that Bacteroides play important roles 
in host physiology beyond the intestine by modulating the metabolic activity of 
other commensal bacteria.  
Within the Firmicutes phylum, which is comprised of gram-positive, spore 
forming, obligate anaerobes, the most studied group of commensal bacteria in 
regard to modulation of immune cell function is the class Clostridia (Figure 2). 
Similar, to B. fragilis, Clostridium spp. isolated from mouse and human feces can 
promote the differentiation and function of CD4+ Foxp3+ Tregs in the mouse colon 
and are sufficient to protect mice from experimental colitis (Atarashi et al., 2013; 
Atarashi et al., 2011). Colonization of germ-free mice, which have enlarged ceca, 
by chloroform-resistant Clostridium spp. resulted in significantly reduced cecum 
size due to Clostridium-dependent fermentation of dietary fiber and production of 
short-chain fatty acids (SCFAs) as metabolic by-products (Furusawa et al., 
2013). Consistent with the hypothesis that gut metabolism and immune cell 
homeostasis are two related processes, optimal induction of colonic Treg 
responses by Clostridium spp. was dependent on metabolism of dietary fiber and 
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subsequent production of SCFAs (Arpaia et al., 2013; Atarashi et al., 2013; 
Furusawa et al., 2013; Smith et al., 2013b).  
The cellular and molecular mechanisms by which SCFAs influence 
immune cell function have begun to be elucidated. SCFAs could directly promote 
Treg immune-suppressive function through Treg-intrinsic expression of the SCFA 
receptor, GPR43 (Smith et al., 2013b). Butyrate also promoted acetylation at the 
Foxp3 locus and the Foxp3 protein (Arpaia et al., 2013; Furusawa et al., 2013), 
which have been previously shown to enhance Foxp3 stability and function (van 
Loosdregt et al., 2010; Zhang et al., 2012). Alternatively, butyrate and propionate 
could function independently of Tregs by suppressing DC production of pro-
inflammatory cytokines and augmenting their ability to induce peripheral Treg 
differentiation (Arpaia et al., 2013). Furthermore, the SCFA butyrate was shown 
to promote Tregs at extra-intestinal tissues such as the spleen and peripheral 
lymph nodes (Arpaia et al., 2013). More recently, it was demonstrated that 
sensing of SCFAs by the metabolite receptors GPR43 on non-hematopoietic 
cells promote activation of the NLRP3 inflammasome and is critical for SCFA-
induced host protection from intestinal inflammation and injury (Macia et al., 
2015). Collectively, bacteria from the genus Clostridium are prominent members 
of the luminal microbiota that induce tissue protective, immunoregulatory 
responses through production of microbial-derived metabolites.   
Anatomical restriction of B. fragilis and Clostridium spp. to the lumen of 
the intestine is dependent on the presence of physical and biochemical barriers 
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that limit interactions of commensal bacteria with IECs and potential translocation 
to the underlying connective tissues of the intestinal lamina propria (Figure 2). 
Mucus, which is secreted by specialized epithelial cells known as goblet cells, 
forms a dense gel-like layer on the apical surface of the intestinal epithelium and 
is composed of mucin glycoproteins including the highly glycosylated mucin 
MUC2 (Johansson et al., 2011). In the colon, mucus is organized into an inner 
mucus layer, which is approximately 50 µm thick in mice and is firmly attached to 
the surface of epithelial cells, and an outer non-epithelial attached layer, which is 
approximately 100 µm thick in mice (Johansson et al., 2011). Luminal 
commensal bacteria in the colon are restricted to either the lumen or the outer 
mucus layer whereas the inner mucus is mostly devoid of commensal bacteria 
with the exception of some epithelial-associated species (Johansson et al., 
2011), which will be discussed in the following section. Although B. fragilis 
colonizes the lumen, it could bind intestinal mucins and was found within the 
colon mucus layer of gnotobiotic mice dual-colonized with E. coli and B. fragilis 
(Huang et al., 2011). These data are supported by the finding that in the distal 
colon, members of Bacteroidales are found near the inner mucus layer while 
Firmicutes are found more evenly distributed throughout the lumen (Earle et al., 
2015). In studies interrogating how the microbiota regulates mucus production 
and integrity, it was demonstrated that the colon inner mucus layer of germ-free 
mice was penetrable to bacteria-sized beads and that colonization of these mice 
with feces from conventional animals restored mucus integrity and anatomical 
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segregation of commensal bacteria from the epithelium at 6 weeks post-
colonization (Johansson et al., 2015).  
In the small intestine, the mucus layer, although much less defined than in 
the colon, is about 50 µm thick in mice and also promotes physical separation 
between most luminal commensal bacteria and the epithelium (Johansson et al., 
2011). In mice deficient in the mucin glycoprotein MUC2, physical separation 
between commensal bacteria and the intestinal epithelium was lost resulting in 
the development of spontaneous colitis (Shan et al., 2013; Van der Sluis et al., 
2006). It was described that MUC2 in the mucus layer of the small intestine also 
actively participated in promoting immune tolerance to luminal antigens by 
conditioning intestinal DCs (Shan et al., 2013). Recognition and uptake of MUC2 
by DCs enhanced their expression of the immunoregulatory cytokines Il10, Tgfb1 
and limited their ability to induce T cell proliferation and production of the 
proinflammatory cytokine IFNγ (Shan et al., 2013). These data indicate that 
mucus secretion is an important mechanism that restricts dissemination of 
luminal commensal bacteria and supports immunological tolerance to luminal 
commensal antigens. 
In addition to mucus, antimicrobial peptides (AMPs) are small molecular 
weight proteins secreted into the lumen of the intestine that limit colonization of 
commensal bacteria and promote physical separation between commensal 
bacteria and the intestinal epithelium. AMPs are produced by virtually all IECs 
but the expression of a subset of AMPs such as the C-type lectin regenerating 
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islet-derived protein 3γ (REGIIIγ) is enriched in specialized IECs such as Paneth 
cells in the small intestine (Hooper et al., 2012). AMPs are concentrated to the 
epithelial surface to limit apical attachment of commensal bacteria normally 
restricted to the lumen (Vaishnava et al., 2011). It was also demonstrated that 
production of REGIIIγ could be induced by TLR signaling, as IEC-intrinsic 
deletion of Myd88 resulted in loss of commensal-epithelium segregation 
(Vaishnava et al., 2011). Collectively, these data suggest that recognition of 
commensal bacteria by TLRs initiates regulatory pathways that promote 
anatomical restriction. Recently, it was shown that the REGIII family proteins 
recognize and target commensal bacteria by binding to surface carbohydrates 
and forming an oligomeric membrane-permeabilizing pore (Mukherjee et al., 
2014). The gram-negative bacteria-derived component lipopolysaccharide (LPS) 
inhibited REGIIIα pore-forming activity, providing a mechanism by which REGIII 
family proteins are bactericidal to gram-positive but not gram-negative bacteria. 
Other AMPs such as lipocalin 2 and calprotectin (S100A8/9), which limit 
microbial access to micronutrients such as zinc, manganese and iron, are likely 
candidates that control the gram-negative commensal populations in the 
intestinal lumen (Behnsen et al., 2014; Corbin et al., 2008; Diaz-Ochoa et al., 
2014; Kehl-Fie et al., 2011; Liu et al., 2012).  
A third mechanism by which the host limits commensal attachment to the 
epithelium is through secretory IgA. IgA is the most abundant immunoglobulin 
produced in mammals and play a critical role in immune defense at the intestinal 
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barrier surface. Induction of IgA in the intestine occurs predominantly in the PPs 
and isolated lymphoid follicles (ILFs) of the small intestine and, similar to mucins 
and AMPs, is highly dependent on the microbiota (Cerutti and Rescigno, 2008; 
Macpherson et al., 2012; Macpherson et al., 2008). IgA secreted by plasma cells 
in these tissues is covalently bound to the polymeric immunoglobulin receptor 
(pIgR) and transported through IECs via intracellular vesicles. Once released into 
the lumen, IgA restricts commensal bacteria from associating with the epithelium 
by binding to the surface of bacteria and neutralizing their ability to trigger 
inflammation (Cerutti and Rescigno, 2008; Macpherson et al., 2012). Mice-
deficient in pIgR displayed increased penetration of commensal bacteria to the 
mesenteric lymph node (mLN) and systemic antibody responses to commensal 
bacteria. IgA can be induced by both T-dependent and T-independent 
mechanisms. While high affinity IgA from T-dependent pathways is important for 
protection from mucosal pathogen colonization, low-affinity, polyreactive IgA from 
T-independent pathways is generally necessary for confining commensal 
bacteria to the intestinal lumen (Cerutti and Rescigno, 2008; Macpherson et al., 
2008). In support of a role for IgA in anatomical containment of commensal 
bacteria to the intestinal lumen, it was shown that IgA selectively labels 
colitogenic bacteria in the intestine such as members of Prevotellaceae, 
Helicobacter and SFB and likely limits their ability to stimulate the host immune 
system (Bunker et al., 2015; Palm et al., 2014). Interactions between the luminal 
microbiota and IgA are likely reciprocal as varying IgA levels in the gut is in part a 
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function of microbiota composition (Moon et al., 2015). Taken together, mucus, 
AMPs and secretory IgA are three of the main host mechanisms that 
cooperatively serve as important regulators that restrict commensal bacteria to 
the lumen of the GI tract.  
 
1.1.2 Epithelial-associated commensal bacteria 
Although most commensal bacteria are restricted to the intestinal lumen, a small 
fraction can penetrate the mucus layer and colonize the surface of IECs. 
Sequencing of 16S rDNA on the surface of the intestinal epithelium has revealed 
the presence of epithelial-associated commensal bacteria that include members 
of the Bacteroidetes and Firmicutes phyla at levels of about 2-3 logs less than 
those observed for luminal bacteria (Hill et al., 2010; Vaishnava et al., 2011). The 
most notable example in mice is SFB, a member of the Firmicutes phylum, which 
colonizes and attaches to IECs of the terminal ileum (Gaboriau-Routhiau et al., 
2009; Ivanov et al., 2009). Colonization of mice with SFB results in elevated 
Th17 cell responses in the small intestine lamina propria, which are associated 
with both intestinal tissue protection from mucosal pathogen infection and 
susceptibility to mouse models of autoimmune arthritis and multiple sclerosis 
(Lee et al., 2011; Wu et al., 2010). Recent studies addressing the mechanisms 
by which SFB induces Th17 cells demonstrated that a diverse array of cellular 
and molecular pathways are involved. Host-specific attachment to IECs by SFB 
was necessary for the generation of Th17 cell responses as they were induced in 
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mice only following colonization with mouse but not rat SFB (Atarashi et al., 
2015). In additional studies, it was demonstrated that local induction of Th17 
responses in the lamina propria was dependent on epithelial cell production of 
serum amyloid proteins 1 and 2 (SAA1/2) (Ivanov et al., 2009; Sano et al., 2015). 
SFB stimulated production of IL-22 by innate lymphoid cells (ILCs), which 
activates epithelial STAT3 to promote SAA1/2 (Sano et al., 2015). Therefore, 
SFB is an epithelial-associated commensal bacterium that elicits selective 
immune responses beneath the intestinal epithelium. 
Direct recognition of SFB is likely mediated by lamina propria 
mononuclear phagocytes (MNPs) that actively sample bacteria in the intestinal 
lumen (Figure 3). Subsets of lamina propria MNPs that express the fractalkine 
receptor CX3CR1 have been shown to sample antigens by extending 
transepithelial dendrites across the intestinal epithelium (Niess et al., 2005; 
Rescigno et al., 2001). Although these phagocytes are believed to be non-
migratory and only stimulate local mucosal immune responses, one report 
suggests that they could carry commensal bacteria antigens to the mLN to 
stimulate both T cell and IgA responses (Diehl et al., 2013). Migration of 
CX3CR1-expressing cells to the mLN and subsequent mucosal immune 
responses were regulated by MYD88-dependent recognition of commensal 
bacteria (Diehl et al., 2013). In contrast, it was recently demonstrated that 
CX3CR1+ cells in the small intestine can acquire and transfer soluble antigens via 
the gap junction protein Connexin 43 to CD103+ DCs, which then migrate to 
 16 
draining lymph nodes to induce antigen-specific T cell responses (Mazzini et al., 
2014). In recent studies, however, it was recently shown that intestinal CX3CR1+ 
but not CD103+ mononuclear phagocytes are responsible for antigen-specific 
Th17 cell induction by SFB (Panea et al., 2015). Although further investigation is 
necessary to delineate the precise contribution of MNPs to recognition of 
epithelial-associated commensal bacteria, it can be concluded that generation of 
immune cell responses by these bacteria collectively requires lamina propria 
phagocytes that actively sample bacteria attached to the intestinal epithelium. 
Similar to their functions in regulating luminal commensal bacteria, host 
mechanisms such as AMPs and IgA are critical regulators of epithelial-
associated commensal bacteria. Consistent with the specificity of REGIIIγ for 
gram-positive bacteria, REGIIIγ downstream of MYD88 signaling was 
demonstrated to restrict expansion of SFB on the epithelial surface as Reg3g-
deficient mice had increased epithelial colonization of SFB and another epithelial-
associated bacterium Eubacterium rectale in the small intestine (Vaishnava et al., 
2011). Increased commensal colonization at intestinal epithelial surfaces due to 
loss of REGIIIγ resulted in increased frequencies of lamina propria T helper 1 
(Th1) but not Th17 cells. Since total levels of SFB were not altered in Reg3g-
deficient mice, these data suggest that dysregulated epithelial colonization by 
SFB may skew CD4 T cells towards a Th1 cell response. A role for AMPs in 
restricting colonization of epithelial-associated commensal bacteria was also 
demonstrated in mice ectopically expressing the human α-defensin gene Defa5 
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(Salzman et al., 2010). Analyses of the microbiota composition in the distal small 
intestine of these mice demonstrated that while the amount of total bacteria was 
similar to littermate controls, Defa5-transgenic (Defa5-Tg) mice had significantly 
reduced colonization of SFB. In support of a role for AMPs in regulating 
epithelial-associated bacterial species, cytokine responses that promote AMP 
expression, such as IL-22, were recently demonstrated to suppress SFB 
colonization (Qiu et al., 2013; Upadhyay et al., 2012). In addition, pathways and 
molecules associated with IL-22 production in the intestine, such as the aryl 
hydrocarbon receptor (Ahr) and RORγt+ ILC responses also direct commensal 
colonization of the intestinal epithelial surface (Qiu et al., 2013). Ahr-deficient 
mice, which have reduced RORγt+ ILCs, demonstrated expansion of SFB and 
increased small intestine Th17 cells (Qiu et al., 2013). Finally, IgA is also 
involved in restricting colonization by SFB as demonstrated by expansion of this 
commensal bacterium in the feces of Iga-deficient mice (Suzuki et al., 2004). 
Collectively, these data highlight a critical role for these biochemical and cellular 
mechanisms in regulating colonization of SFB on the intestinal epithelial surface.  
Commensal bacteria that are found in the lumen of the intestine can also 
be epithelial-associated. Electron microscopy (EM) and immunofluorescence 
revealed that B. fragilis could penetrate the inner mucus layer and colonize the 
crypts of the large intestine. This was demonstrated to be dependent on both 
host-derived and bacterial-intrinsic factors. Colonic crypt colonization by B. 
fragilis was dependent on induction of Tregs by PSA (Round et al., 2011). In a 
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follow-up study by the same group, it was shown that expression of commensal 
(ccf) genes by B. fragilis could promote colonization of the bacteria at colonic 
crypts (Lee et al., 2013). It was hypothesized that host-derived glycan structures 
could induce the expression of ccf genes, consistent with the dependence of 
Bacteroides spp. on host-derived carbohydrates for intestinal colonization and 
survival (Wexler, 2007). It has also been reported that B. fragilis, although an 
anaerobe, can tolerate and benefit from nanomolar concentrations of oxygen, 
which is higher at the epithelial surface relative to the lumen of the intestine 
(Baughn and Malamy, 2004). Additionally, although Clostridium spp. typically 
reside in the intestinal lumen, EM analysis of the colon of Clostridium spp. 
colonized mice also demonstrated their presence on the epithelial surface 
(Atarashi et al., 2013). In support of a role for Clostridium spp. in modulating 
epithelial cell responses, cecal extracts from Clostridium-colonized mice could 
induce primary IECs to produce the Treg-inducing cytokine TGF-β (Atarashi et 
al., 2013). Taken together, these data suggest that commensal bacteria-elicited 
immune responses and commensal bacteria-intrinsic factors cooperatively permit 
stable intestinal colonization by epithelial-associated commensal bacteria. 
Further analyses are required to determine whether the immune cell responses 
promoted by Bacteroides and Clostridia members are associated with their 
localization in either the lumen or the epithelial surface. Chapter 2 of this thesis 
will compare tissue-specific immune responses induced by epithelial-associated 
commensal bacteria versus LRCs. 
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1.1.3 Lymphoid tissue-resident commensal bacteria  
Tissues beyond the intestinal epithelium are not typically thought of as sites for 
commensal bacteria colonization. Although pathogens can penetrate the 
intestinal epithelium, evade macrophage killing and in some cases thrive in 
intestinal tissues, commensal bacteria that breach the intestinal barrier are 
typically phagocytosed and cleared by lamina propria macrophages (Macpherson 
and Harris, 2004; Smith et al., 2011; Varol et al., 2010). However, recent data 
provided evidence that some commensal species could stably colonize the 
interior of gut-associated lymphoid tissues such as PPs and mLN of healthy mice 
and humans (Obata et al., 2010; Sonnenberg et al., 2012) (Figure 4). In a 
seminal study by Kiyono and colleagues, sequencing of 16S rDNA in the interior 
of intestinal lymphoid tissues revealed the presence of specific groups of 
commensal bacteria including Alcaligenes spp., Ochrobactrum spp., Serratia 
spp. and Burkholderia spp. Alcaligenes spp. represented the most abundant 
lymphoid tissue-resident commensal in the PPs. It was observed that 16S rDNA 
of some of these bacteria were detected in the PP DCs of healthy mice, 
suggesting the possibility of intracellular survival in DCs. These data support a 
hypothesis in which lymphoid tissue-resident commensal bacteria can 
preferentially access host lymphoid tissues and evade clearance by host immune 
cells. Indeed, Alcaligenes spp. can be transcytosed by specialized IECs known 
as M cells from the lumen of the small intestine to PPs (Sato et al., 2013).  
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It is interesting to note that all of the lymphoid tissue-resident species 
identified so far are also aerobic, environmental microbes, resistant to a broad 
spectrum of antibiotics and associated with opportunistic nosocomial infections, 
particularly in the respiratory tract (Amoureux et al., 2013; Chain et al., 2011; 
Davies and Rubin, 2007; Mahenthiralingam et al., 2008). Some of these species, 
such as Burkholderia spp. and Serratia spp. are well adapted to survive on 
inanimate surfaces and also in host cells (Fedrigo et al., 2011; Valvano et al., 
2005). Whether these features are related to their unique colonization pattern in 
the intestine is not well understood and requires further investigation. However, 
analyses in Alcaligenes-colonized mice demonstrated that Alcaligenes spp. is 
sufficient to promote robust Alcaligenes-specific and non-Alcaligenes-specific IgA 
(Obata et al., 2010). Furthermore, B cell-deficient CBA/N xid and Iga-deficient 
mice had reduced numbers of Alcaligenes spp. in the PP. These data suggest 
that in contrast to luminal and epithelial-associated commensal bacteria, which 
are restricted by IgA, optimal colonization by Alcaligenes spp. is dependent on 
IgA-producing B cells (Obata et al., 2010). Consistent with the notion that 
mucosal DCs are restricted from migrating beyond the mLN to systemic lymphoid 
tissues (Macpherson and Uhr, 2004), Alcaligenes-specific IgG responses were 
not detected in the periphery of Alcaligenes-colonized mice (Obata et al., 2010).  
Recently, anatomical containment of the lymphoid tissue-resident-
commensal bacteria Alcaligenes xylosoxidans (also referred to as 
Achromobacter xylosoxidans) was demonstrated to be dependent on IL-22 
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produced by RORγt+ ILCs (Sonnenberg et al., 2012) (Figure 4). Rag1-deficient 
mice depleted of ILCs experienced low-grade systemic inflammation that was 
associated with dissemination of Alcaligenes spp. to the liver, spleen and blood 
(Sonnenberg et al., 2012). Administration of IL-22 or the AMP calprotectin to ILC-
depleted Rag1-deficient mice partially restored anatomical containment of 
Alcaligenes xyloxidans, suggesting a role for IL-22-induced factors such as 
AMPs in restricting Alcaligenes to intestinal lymphoid tissues (Sonnenberg et al., 
2012). More recently, it was revealed that secretory IgA from breast milk could 
restrict translocation of Ochrobactrum anthropi from the neonatal gut to the 
draining lymph node (Rogier et al., 2014), suggesting a role for IgA in anatomical 
containment of other lymphoid tissue-resident commensal bacteria. These data 
provide potential mechanisms for anatomical containment of LRCs and also 
highlight that dysregulated localization of normally beneficial commensal bacteria 
can promote pathological inflammation, a condition often associated with human 
chronic inflammatory diseases. This idea will be discussed further in the following 
section. However, despite these advances, lymphoid tissue-resident commensal 
bacteria are still the least understood class of bacteria that colonize the intestine. 
Studies in Chapter 2 and 3 will interrogate the functional significance of LRC 
colonization in the context of immune cell homeostasis and intestinal injury.  
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1.2 Anatomical localization of intestinal commensal bacteria during chronic 
inflammatory diseases 
Analyses of the composition and localization of the human and mouse microbiota 
have established that in some contexts, commensal bacteria can promote 
chronic inflammatory disease through dysbiosis and/or bacterial translocation 
(Hooper et al., 2012; Kamada et al., 2013b). Most studies thus far have focused 
on how changes in the composition of the luminal microbiota can influence the 
development of disease. For example, IBD and obesity were associated with a 
dysbiotic microbiota that was sufficient to transfer disease to healthy hosts 
following cohousing or fecal transfer (Garrett et al., 2007; Vijay-Kumar et al., 
2010). The role of dysbiosis in other chronic diseases such as AIDS and cancer 
has been extensively reviewed elsewhere (Cho and Blaser, 2012; Elinav et al., 
2013; Ivanov and Honda, 2012; Kaur et al., 2011; Manichanh et al., 2012; 
Pflughoeft and Versalovic, 2012; Schwabe and Jobin, 2013). Alternatively, 
prebiotic and probiotic administration of beneficial microbes have been reported 
to promote intestinal health and limit pathologic inflammation (Bron et al., 2012; 
Lebeer et al., 2010). However, an emerging theme of the studies performed in 
the last decade is that dysregulated localization, not just dysbiosis, of normally 
beneficial commensal bacteria can be detrimental to the host and is often a major 
contributing factor to the development and pathogenesis of chronic inflammatory 
diseases. Chronic viral infections, IBD, metabolic syndromes and cancer have all 
been associated with dysregulated localization of commensal bacteria. The 
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following sections will highlight disease settings where anatomical restriction of 
luminal, epithelial-associated and lymphoid tissue-resident commensal bacteria 
is disrupted and may contribute to chronic inflammatory disease. 
 
1.2.1 Chronic viral infections 
Chronic viral infections are strongly associated with the loss of intestinal barrier 
function, commensal bacteria translocation to peripheral tissues and induction of 
systemic inflammation in humans (Ancuta et al., 2008; Balagopal et al., 2008; 
Brenchley et al., 2006; Jiang et al., 2009; Redd et al., 2009). A seminal finding by 
Douek and colleagues demonstrated that patients chronically infected with HIV, 
and those that have progressed to AIDS, exhibit elevated plasma LPS levels, 
suggesting that translocation of gram-negative bacteria components or whole 
gram-negative bacteria occurs in these diseases (Ancuta et al., 2008; Brenchley 
et al., 2006). Consistent with elevated plasma LPS, the peripheral blood of AIDS 
patients exhibited signs of systemic immune activation such as the presence of 
elevated serum IFNα, activated monocytes and activated circulating CD8+ T 
cells, hallmarks that contribute to viral replication, dissemination and disease 
progression (Ancuta et al., 2008; Brenchley et al., 2006; Marchetti et al., 2008). 
Interestingly, SIV-infected sooty mangabeys, which are natural hosts of SIV that 
do not develop AIDS, did not exhibit loss of intestinal barrier function, bacterial 
translocation or systemic inflammation (Estes et al., 2010). Bacterial 
translocation has been observed in other chronic viral infections such as HCV 
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and HBV. Patients infected with HCV and HBV had elevated plasma LPS, which 
was associated with parameters of systemic immune activation such as elevated 
serum levels of the TLR4-co-receptor CD14 and IL-6 (Sandler et al., 2011). 
Taken together, these data suggest that loss of anatomical restriction of gram-
negative commensal bacteria-derived products contribute to the pathogenesis of 
chronic viral infections.  
Although it remains unclear whether whole commensal bacteria are found 
in the periphery of these patients or which commensal species promote disease 
progression, recent studies suggest that HIV and HCV-infected patients have 
elevated serum IgG responses to the lymphoid tissue-resident commensal 
bacteria Alcaligenes (Sonnenberg et al., 2012; Tatro et al., 2014). In support of a 
role for these bacteria in disease pathogenesis and systemic inflammation, levels 
of Alcaligenes/Achromobacter-specific IgG were associated with hallmarks of 
AIDS such as reduced CD4+ T cell counts and increased proportion of activated 
CD4+ T cells, and parameters of HCV progression including increased serum 
bilirubin and decreased serum albumin and platelets. Potential translocation of 
Achromobacter/Alcaligenes members in HIV-infected patients agrees with 
previous reports that Burkholderiales 16S rDNA, which includes the genus 
Achromobacter and Alcaligenes, was present in the peripheral blood of some 
patients (Merlini et al., 2011). Other groups of bacteria such as members of the 
orders Enterobacteriales, Lactobacillales and Pseudomonadales were also 
identified in the serum of these patients. Altogether, these data suggest that HIV 
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infection is strongly associated with dysregulated anatomical localization of 
various commensal bacterial communities. 
Loss of cellular pathways that promote intestinal epithelial barrier function 
may also contribute to bacterial translocation observed in chronic HIV and HCV 
infection. RORγt+ ILCs, which are potent sources of IL-17 and IL-22, and the 
CD103+ immunoregulatory DCs were found to be dramatically reduced in SIV 
infection (Klatt et al., 2012; Li and Reeves, 2012; Xu et al., 2012). More recently, 
it was demonstrated that ILC3s are irreversibly depleted during acute HIV 
infection (Kloverpris et al., 2016; Zhang et al., 2015). These data are consistent 
with the role of RORγt+ ILCs in regulating the anatomical containment of SFB 
and LRCs (Qiu et al., 2013; Sonnenberg et al., 2012). Given that antiretroviral 
therapy is inadequate to completely control bacterial translocation (Merlini et al., 
2011), further work is required to define the pathways that regulate intestinal 
barrier integrity and systemic inflammation in chronic viral infections. It is also 
important to highlight that patients with chronic viral infections often exhibit 
intestinal, metabolic and cardiovascular symptoms, which have all been 
associated with dysregulated localization of commensal bacteria (Gandhi et al., 
2012; Keating et al., 1995; Samaras et al., 2007; Sheikh et al., 2008). Therefore, 
it is possible that bacterial translocation observed in HIV and HCV patients may 
be related to the onset of these diseases. 
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1.2.2 Inflammatory bowel disease 
IBD, which includes Crohn’s disease (CD) and ulcerative colitis (UC), is strongly 
associated with dysregulated localization of commensal bacteria in humans. It is 
well documented that dysregulated host-commensal bacteria interactions, as 
indicated by parameters such as elevated serum LPS and bacterial DNA, play a 
major role in the pathogenesis of IBD by promoting inappropriate immune 
activation and chronic inflammation (Brenchley and Douek, 2012; Gardiner et al., 
1995; Gutierrez et al., 2009; Lakatos et al., 2011; Obermeier et al., 2005). 
Changes in localization of commensal bacteria in IBD have been observed in the 
form of both bacterial translocation and increased bacterial colonization on the 
surface of the intestinal epithelium. Studies have implicated a role for increased 
colonization of the ileum by an adherent-invasive strain of Escherichia coli 
(AIEC). The predominance of AIEC epithelial colonization was demonstrated to 
contribute to chronic inflammation and immunopathology in human IBD 
(Darfeuille-Michaud et al., 2004; Lee et al., 2011; Small et al., 2013). To analyze 
the composition of disseminated commensal bacteria in gut-associated lymphoid 
tissues, one recent report identified that Escherichia and Shigella were enriched 
in the mLN of CD patients (O'Brien et al., 2014; Small et al., 2013). Similar 
findings were reported by a study that sequenced 16S rDNA from micro-
dissected intestinal biopsies. Facultative anaerobes such as Enterobacteriaceae 
were enriched in micro-dissected ulcer biopsies of CD patients (De Hertogh et 
al., 2006). Collectively, these data suggest that increased epithelial and lymphoid 
 27 
tissue colonization by commensal bacteria are hallmarks of and may contribute 
to the pathogenesis of IBD. To further investigate bacterial translocation to extra-
intestinal sites in IBD, one study identified the presence of Enterococcus faecalis, 
a common member of the luminal flora, in the visceral fat of UC and CD patients 
(Zulian et al., 2013). In addition, it was recently demonstrated that pediatric CD 
patients exhibit increased serum IgG specific for Alcaligenes spp. (Sonnenberg 
et al., 2012), suggesting that impaired localization and systemic dissemination of 
LRCs is also associated with disease pathogenesis. Studies in Chapter 3 of this 
thesis will directly interrogate the role of LRC colonization in a mouse model of 
acute intestinal injury.  
While it is unclear whether translocation of commensal bacteria is the 
cause or effect of IBD, several genetic polymorphisms in genes involved in host-
microbial interactions are strongly associated with IBD (Jostins et al., 2012). 
Among these, the most prevalent are polymorphisms in Atg16l1, Il23r, Nod2 and 
Il10r (Cho, 2008; Gutierrez et al., 2014). ATG16L1, a component of the 
autophagy machinery, is involved in intracellular degradation of bacteria (Cadwell 
et al., 2008). IL-23R is expressed on innate and adaptive immune cells that 
promote immunity to intestinal pathogens and maintain intestinal barrier function 
(Duerr et al., 2006). NOD2 is a pattern recognition receptor (PRR) that 
recognizes peptidoglycan from bacteria and triggers anti-bacterial immune 
responses (Cho and Abraham, 2007). IL-10 is a potent anti-inflammatory 
cytokine produced by innate and adaptive immune cells that maintain tissue 
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homeostasis by suppressing pro-inflammatory responses (Saraiva and O'Garra, 
2010; Shah et al., 2012). Therefore, loss of function mutations in these genes 
may contribute to enhanced bacterial translocation and intestinal inflammation.  
 
1.2.3 Metabolic diseases 
Diabetes and obesity were two of the first extra-intestinal diseases to be 
associated with commensal bacteria-derived chronic inflammation (Ley et al., 
2005; Ley et al., 2006; Turnbaugh et al., 2006). In a mouse model of diet-induced 
obesity, mice fed a high-fat diet (HFD) for four weeks had increased 
concentrations of bacterial DNA and LPS in the blood, mesenteric adipose tissue 
and mLN as well as increased adherence of commensal bacteria to the intestinal 
epithelium (Amar et al., 2011; Cani et al., 2007). Analysis of translocated bacteria 
species in the mesenteric adipose tissue identified members of the family 
Enterobacteriaceae and Enterococcus spp. and Lactobacillus spp. (Amar et al., 
2011), which are commensal bacteria commonly found in the lumen of the 
intestine. Translocation of commensal bacteria was associated with a loss of 
intestinal barrier integrity (Amar et al., 2011), increased levels of IL-1, IL-6 and 
TNFα in adipose depots and the onset of diabetes. Many of these parameters 
were markedly reduced in HFD-fed mice lacking the intracellular PRR Nod1 
(Amar et al., 2011; Shi et al., 2006), TLR4 (Shi et al., 2006) or the TLR4-co-
receptor CD14 (Amar et al., 2011; Cani et al., 2007), suggesting that recognition 
of translocated commensal bacteria can drive tissue inflammation and disease 
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pathology. In support of these findings, repeated subcutaneous injections of LPS 
to mice fed a normal chow (NC) was sufficient to recapitulate many of the 
diabetic symptoms observed in mice fed a HFD (Cani et al., 2007). Altogether, 
these findings indicate that impaired anatomical localization is a hallmark and 
significant contributor of diet-induced obesity. 
Obesity is associated with significant changes in the composition of the 
luminal microbiota. For example, mice deficient in TLR5 are highly susceptible to 
diet-induced obesity, which was associated with a dysbiotic microbiota that could 
confer disease to wild-type germ-free mice following fecal transfer (Vijay-Kumar 
et al., 2010). In contrast, mice deficient in lymphotoxin β signaling are resistant to 
diet-induced obesity, and cecal contents from HFD-fed lymphotoxin β receptor 
(Ltbr)-deficient mice were less efficient in promoting weight gain in wild-type 
germ-free recipients compared to cecal contents from HFD-fed wild-type mice 
(Upadhyay et al., 2012). Interestingly, normal chow diet (NCD)-fed Ltbr-deficient 
mice, which lacked IL-23 and IL-22, demonstrated increased colonization by 
SFB. Whereas SFB levels were reduced in HFD-fed wild-type, SFB levels in 
HFD-fed Ltbr-deficient mice remained high relative to wild-type controls. 
Furthermore, administration of IL-22 or IL-23-Ig restored HFD-induced changes 
in SFB and obesity in Ltbr-deficient mice. Although bacterial translocation was 
not analyzed in these studies, it is interesting to speculate that specific groups of 
commensal bacteria that promote or limit disease are more or less likely, 
respectively, to disseminate to adipose depots and subsequently trigger chronic 
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inflammation. Nevertheless, these data support the hypothesis that specific 
immune pathways and/or commensal bacteria communities can promote (e.g. 
LTβ signaling, Enterobacteriaceae) or limit (e.g. TLR5, SFB) the development of 
obesity. 
Other metabolic diseases are also associated with dysbiosis and loss of 
normal localization of commensal bacteria in the intestine. For example, plasma 
LPS levels are significantly elevated in patients with chronic hepatitis, alcoholic 
and non-alcoholic liver disease and have been associated with severe liver 
dysfunction (Garcia-Alvarez et al., 2012; Lin et al., 1995; Wiest et al., 2014). In a 
mouse model of non-alcoholic fatty liver disease (NAFLD), it was demonstrated 
that a dysbiotic microbiota in inflammasome-deficient mice could promote hepatic 
steatosis and Tnf expression due to translocation of TLR4 and TLR9 agonists 
through the portal circulation to the liver (Henao-Mejia et al., 2012). Although 
translocation of intact bacteria was not detected in the portal vein or liver, these 
data suggest that translocation of commensal-derived products alone to extra-
intestinal sites can promote immune activation and tissue pathology in this 
mouse model of liver disease. More recently, it was shown that emulsifiers 
commonly found in processed foods disrupt the mucus barrier on the surface of 
the intestinal epithelium and result in altered microbiota composition on the 
surface of the intestinal epithelium (Chassaing et al., 2015). These changes were 
associated with the development of metabolic disease, which could be 
recapitulated by transfer of the altered microbiota to germ-free mice. Collectively, 
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a disturbance of metabolic homeostasis is often associated with changes in 
anatomical localization of commensal bacteria.  
 
1.2.4 Cardiovascular diseases 
An increasing body of literature has revealed that the inflammatory and metabolic 
effects of the gut microbiota contribute to the development and pathogenesis of 
cardiovascular diseases (Libby, 2002, 2006). Several studies have identified 
changes in the composition of luminal commensal bacteria and investigated the 
mechanisms by which commensal-dependent metabolic pathways can impact 
disease. In one study, fecal microbiota analyses of healthy controls and 
atherosclerosis patients demonstrated a selective enrichment of the genus 
Collinsella and reduction in the genus Eubacterium and Roseburia in patients 
(Karlsson et al., 2012). By measuring the metabolic activity of the luminal 
microbiota, it was determined that the microbiota of healthy controls was 
enriched for genes involved in the synthesis of anti-inflammatory and anti-oxidant 
compounds whereas the microbiota of atherosclerosis patients was enriched for 
genes in the peptidoglycan biosynthesis pathway. These data suggest that 
changes in composition of luminal commensal bacteria can alter the 
inflammatory and metabolic status of the host to promote atherosclerosis. In 
addition, a separate study demonstrated that increased levels of the commensal-
dependent dietary metabolite, trimethylamine-N-oxide (TMAO), were associated 
with an increased risk of adverse cardiovascular events (Tang et al., 2013). This 
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is supported by studies in which metabolism of the dietary metabolite L-carnitine, 
which is abundant in red meat, produces TMAO and accelerates onset of 
atherosclerosis (Koeth et al., 2013). Taken together, these findings establish a 
link between luminal commensal bacteria, metabolism and atherosclerosis. 
Despite these findings, much less is known about the role of disrupted 
anatomical localization of commensal bacteria in cardiovascular disease. 
However, one study sequenced 16S rDNA from atherosclerotic plaques of 
human patients and demonstrated the presence of bacteria that are normal 
inhabitants of the intestinal lumen including members of the Bacteroidaceae, 
Enterobacteriaceae and Lachnospiraceae families (Koren et al., 2011). These 
data suggest that dissemination of commensal bacteria or commensal bacteria-
derived products to the circulation may be associated with the development and 
pathogenesis of atherosclerosis. However, additional studies are necessary to 
interrogate the origin, cause and contribution of commensal bacteria in 
atherosclerotic plaques. 
  
1.2.5 Cancer 
As previously discussed, translocation of commensal bacteria is commonly 
observed in chronic liver diseases and can contribute to liver fibrosis and 
cirrhosis (Garcia-Alvarez et al., 2012; Lin et al., 1995; Wiest et al., 2014). 
Hepatocellular carcinoma (HCC) is a leading cause of death in patients who 
develop fibrotic and cirrhotic livers due to chronic inflammation. In support of the 
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hypothesis that bacterial translocation promotes liver tumor development, Tlr4-
deficient mice, germ-free mice and mice treated with oral antibiotics were 
protected from hepatocarcinogenesis in a mouse model of chronic liver injury 
(Dapito et al., 2012). This is consistent with a previous report demonstrating that 
LPS-induced liver fibrosis was reduced in Myd88-deficient mice and that hepatic 
satellite cells is the dominant target by which TLR4 ligands promote liver fibrosis 
(Seki et al., 2007). Another cancer associated with dysregulated anatomical 
localization of commensal bacteria is colorectal cancer (CRC). Bacterial 
translocation has been observed in the mLN and serum of CRC patients (Chin et 
al., 2007; Klein et al., 2013; Lescut et al., 1990). These patients also exhibited 
cachexia and elevated serum pro-inflammatory cytokine levels and had a poor 
prognosis. However, studies on specific groups of commensal bacteria that 
disseminate in human colon cancer are limited. Fusobacterium nucleatum, a rare 
member of the human intestinal microbiota, was demonstrated to be strongly 
associated with human colorectal carcinoma and was found to be enriched in 
human colonic adenomas (Kostic et al., 2013). In contrast to commensal bacteria 
such as the enterotoxigenic B. fragilis and AIEC which promote colitis-associated 
cancer (Arthur et al., 2012; Wu et al., 2009), F. nucleatum did not promote colitis 
in mice, but rather increased tumor multiplicity, recruited tumor-promoting 
myeloid cells and generated a pro-inflammatory environment that favored tumor 
development. Since F. nucleatum was also enriched in the fecal microbiota of 
CRC patients, it is likely that increased luminal burden of F. nucleatum 
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contributes to the accumulation of this bacterium in colonic adenomas. Response 
to chemotherapy and immunotherapy was recently demonstrated to be 
dependent on anatomical localization of the microbiota. In contrast to the role for 
F. nucleatum in promoting colon adenomas, cyclophosphamide chemotherapy 
commonly used for solid malignancies injures the small intestine, which results in 
bacterial translocation and activation of anti-tumor CD4 T cell responses (Viaud 
et al., 2013). In a separate study, treatment with the chemotherapeutic agent 
oxaliplatin activated the immune system that was dependent on microbiota 
priming of myeloid cells and reactive oxygen species production (Iida et al., 
2013). More recently, two studies demonstrated that the efficacy of cancer 
immunotherapy via checkpoint inhibitors required the presence of a complete 
microbiota (Sivan et al., 2015; Vetizou et al., 2015). However, whether the 
chemotherapeutic agent oxaliplatin and cancer immunotherapies promote anti-
tumor immunity by altering localization of commensal microbes is not known. 
Future investigations should determine how dysregulated commensal bacteria 
localization can promote or limit cancer development.  
 
1.3 Iron homeostasis in health and disease 
Iron is an essential nutrient for the survival of all living organisms. In humans, 
iron is absorbed from the diet through enterocytes in the duodenum, which is 
then redistributed to the rest of the body in the form of intracellular and 
extracellular iron stores. Because iron is a critical element for many human 
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biological processes, its uptake, storage and transport are tightly regulated by 
multiple molecular mechanisms. Central to this iron-regulatory network is the 
hormone hepcidin (Figure 5). Hepcidin is a 25-amino acid peptide that is 
expressed and secreted primarily by liver hepatocytes. It binds to and results in 
the degradation of the iron exporter ferroportin, a membrane-bound protein that 
is expressed on duodenal enterocytes and reticuloendothelial cells such as 
macrophages (Nemeth et al., 2004b; Zhang et al., 2011). As a result, hepcidin-
ferroportin interactions inhibit iron uptake through the intestine and promote iron 
sequestration in macrophages (Figure 6). To maintain homeostatic levels of 
intracellular and extracellular iron, hepcidin expression is regulated by numerous 
factors including plasma iron levels, inflammatory signals and erythropoiesis 
(Kautz et al., 2014; Nemeth et al., 2004a). Consistent with a role for iron in the 
survival and proliferation of microorganisms including pathogens, multiple studies 
support the hypothesis that hepcidin-mediated iron regulation is a critical host 
pathway to limit pathogen infection (Cassat and Skaar, 2013; Drakesmith and 
Prentice, 2012; Ganz and Nemeth, 2015). However, whether hepcidin-mediated 
iron regulation controls host-commensal bacteria interactions and the immunity 
system is not well understood. The following sections will explore the role of 
hepcidin and iron homeostasis in the context of host-microbe interactions and 
immune cell function. 
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1.3.1 Role of iron homeostasis and hepcidin in host-pathogen interactions 
During inflammation, hepcidin is upregulated and subsequent hepcidin-
ferroportin interactions result in a reduction in plasma iron levels via inhibition of 
iron uptake and sequestration of iron within reticuloendothelial cells (Nemeth et 
al., 2004b). Since most microbial pathogens trigger inflammatory immune 
responses and require iron for survival, hepcidin-mediated hypoferraemia has 
been proposed to be a host-protective response to limit pathogen proliferation 
(Cassat and Skaar, 2013; Drakesmith and Prentice, 2012; Ganz and Nemeth, 
2015). Indeed, hepcidin-deficient mice are susceptible to infections caused by 
Gram-negative bacteria such as Vibrio vulnificus and Yersina enterocolitica 
(Arezes et al., 2015; Quenee et al., 2012). Hepcidin-deficient mice treated with 
hepcidin agonists that induce hypoferraemia were rescued from infection-induced 
mortality, suggesting that hepcidin alone is sufficient to provide host protection 
(Arezes et al., 2015). Furthermore, sera from hepcidin-deficient mice supported 
in vitro growth of V. vulnificus to a greater extent than sera from wild-type mice, 
suggesting that the susceptibility of hepcidin-deficient mice to infection is due to 
elevated systemic iron. Collectively, these data support the hypothesis that 
hepcidin-mediated plasma iron reduction acts to limit the bioavailability of iron to 
invading extracellular pathogens.   
Since some pathogens infect the host by colonizing the intracellular 
compartment of host cells such as macrophages, hepcidin-mediated 
sequestration of intracellular iron may actually promote infection by these 
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intracellular pathogens (Figure 6). Indeed, studies in mouse models revealed that 
macrophages from hepcidin-deficient mice are unable to support the growth of 
intracellular microbes such as Mycobacteria tuberculosis and Salmonella 
enterica serovar enterica Tyhimurium (Nairz et al., 2009; Olakanmi et al., 2007). 
Therefore, although hepcidin may serve to restrict infection by extracellular 
pathogens, re-distribution of intracellular versus extracellular iron by hepcidin 
may promote the survival of pathogens that thrive within host cells. Collectively, 
these data suggest that dysregulated iron homeostasis is associated with altered 
susceptibility to infectious disease. However, more studies are necessary to 
define the role of hepcidin-mediated iron regulation in host protection from 
extracellular versus intracellular microbial pathogens. Chapter 4 of this thesis will 
investigate the role of hepcidin in the generation of anti-microbial immune 
responses by innate and adaptive immune cells. 
 
1.3.2 Role of iron homeostasis in host-commensal bacteria interactions 
The host GI tract is colonized with trillions of microbes that provide multiple 
beneficial functions. Similar to humans and microbial pathogens, many of these 
microbes depend on iron for their survival and persistence in the host. Therefore, 
the iron-regulatory hormone hepcidin could be a critical regulator of host-
commensal bacteria relationships. In support of this hypothesis, a recent study 
reported that regulation of liver hepcidin expression during acute intestinal 
inflammation is dependent on the immune environment and composition of the 
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intestinal microbiota (Shanmugam et al., 2014). During DSS-induced intestinal 
injury, wild-type mice downregulated expression of liver hepcidin whereas Il10-/- 
mice, which are susceptible to intestinal inflammation, upregulated expression of 
liver hepcidin. Differential regulation of hepcidin in wild-type and Il10-/- mice was 
dependent on the intestinal microbiota as co-housing Il10-/- mice with wild-type 
mice abolished this effect. More recently, it was shown that commensal bacteria-
induced IL-1β secreted by macrophages promotes hepcidin expression in 
hepatocytes (Lee et al., 2005; Shanmugam et al., 2015). Collectively, these data 
support the hypothesis that commensal bacteria communities modulate hepcidin 
expression. 
Lactobacillus is a common human commensal bacterium frequently used 
as probiotics. Unlike most organisms many Lactobacillus species have little to no 
requirement for iron and are rapidly outcompeted by other commensal bacteria 
that thrive in the presence of elevated iron such as during dietary 
supplementation and intestinal bleeding (Bailey et al., 2011). To determine the 
effect of iron supplementation on microbiota composition, one study 
demonstrated that anemic African children who received iron-fortified biscuits 
had a high ratio of fecal enterobacteria to probiotic lactobacilli and bifidobacteria 
(Zimmermann et al., 2010). These changes were associated with an increase in 
calprotectin levels, a marker of intestinal inflammation. These data suggest that 
that treatment of anemia using iron replacement therapy may have adverse 
effects and result in a pathogenic and inflammatory gut microbiota. This is indeed 
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supported by the poor efficacy of iron supplementation in the management of 
anemia caused by inflammatory bowel diseases (Rogler and Vavricka, 2014; 
Stein and Dignass, 2013). More studies are necessary to determine 1) the role of 
iron homeostasis in regulating host-commensal relationships during a state of 
health and disorders associated with iron deficiency and 2) whether the iron 
regulatory hormone hepcidin influences iron-mediated changes to host-
commensal interactions. Chapter 4 of this thesis will explore the role of hepcidin 
on host-LRC interactions.  
 
1.3.3 Role of iron homeostasis and hepcidin in immune cell function 
Dysregulated iron homeostasis in animals has been associated with changes in 
innate immune function. In a mouse model of acute wounding, iron 
supplementation skewed macrophage activation to a pro-inflammatory M1 
phenotype and impaired wound healing (Sindrilaru et al., 2011). Treatment of 
iron-supplemented animals with the iron chelator deferoxamine restored wound 
healing, suggesting that iron is necessary and sufficient to promote M1 
macrophage polarization. During infection, Hfe-/- mice, which have impaired 
hepcidin expression and thus decreased intracellular iron stores, are highly 
susceptible to Salmonella and Mycobacterium avium infection (Gomes-Pereira et 
al., 2008; Wang et al., 2008). These data are in contrast to the previous reports 
that hepcidin-deficient macrophages are unable to support intracellular bacteria 
growth due to reduced intracellular iron levels (Nairz et al., 2009; Olakanmi et al., 
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2007). The authors hypothesized that susceptibility of Hfe-/- mice to intracellular 
bacterial infection may be due to an inability of knockout animals to mount an 
innate immune response to the pathogen, as Hfe-/- peritoneal macrophages 
expressed lower levels of the pro-inflammatory cytokines IL-6 and TNFα 
following LPS or Salmonella exposure (Wang et al., 2008). This defect was 
restored in wild-type macrophages treated with a cell-permeable iron chelator or 
overexpressing the iron exporter ferroportin, suggesting that reduced pro-
inflammatory cytokine production is a result of low intracellular iron. Interestingly, 
iron is selectively involved in the microbial sensing through the TLR4 but not the 
TLR2 and TLR3 pathways (Wang et al., 2009). Altogether these data suggest 
that high intracellular iron levels enhance pro-inflammatory cytokine production 
by macrophages. Chapter 4 of this thesis will interrogate the role of hepcidin-
mediated iron homeostasis on cytokine production by innate and adaptive 
immune cells. 
Several studies in humans have demonstrated that impaired iron 
homeostasis results in dysregulated immune responses. In children with iron-
deficient anemia, one study showed that serum IL-6 levels and the oxidative 
burst capacity of neutrophils were significantly reduced compared to healthy 
controls (Ekiz et al., 2005). In contrast, a separated study demonstrated that 
monocytes in patients supplemented with iron produced less IL-6 in response to 
IFNγ (Sonnweber et al., 2011). Although these results suggest that iron is a 
critical regulator of innate immune cell function, it is likely that iron may have both 
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direct effects on immune cell function and indirect effects potentially through 
modulation of the endogenous microbiota. More studies are necessary to dissect 
the interplay between iron homeostasis, the immune system and the gut 
microbiota. 
 
1.3.4 Regulation of hepcidin expression  
Hepcidin expression is regulated at the level of transcription by three main cell-
extrinsic factors: inflammatory stimuli, erythropoiesis and plasma iron levels 
(Figure 5). Cytokines that activate the STAT3 pathway including IL-6 and IL-22 
are strong inducers of hepcidin production (Armitage et al., 2011; Nemeth et al., 
2004a; Smith et al., 2013a). Regulation of hepcidin expression by inflammation is 
consistent with the fact that hepcidin is strongly upregulated in the context of 
infection and tissue inflammation. While inflammatory signals upregulate 
hepcidin, erythropoietic signals such as erythroferrone downregulate hepcidin to 
increase iron availability for erythropoiesis (Kautz et al., 2014). In order to 
maintain homeostatic levels of systemic iron, hepcidin expression is tightly 
controlled by plasma iron levels. High plasma iron promotes hepcidin expression 
to halt iron absorption through the intestine and inhibit its release from 
intracellular stores (Ganz and Nemeth, 2015).  
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1.4 Outline of thesis 
Commensal bacteria colonize distinct sites along the mammalian GI tract. While 
most commensal bacteria are found in the lumen or on the surface of the 
intestinal epithelium, recent studies report the presence of commensal bacterial 
signatures in the interior of intestinal-associated lymphoid tissues. The focus of 
this thesis is to examine interactions between LRCs and the host immune 
system. Chapter 2 will explore the cellular mechanisms by which LRCs colonize 
intestinal-associated lymphoid tissues and the immunological consequences of 
LRC colonization. Chapter 3 will investigate the role of LRC-induced immune 
responses in the context of LRC colonization and intestinal injury. Finally, 
Chapter 4 will define the role of iron homeostasis and the iron regulatory 
hormone hepcidin on LRC colonization and immune cell homeostasis. 
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Figure 1. Anatomical localization of commensal bacteria in the mammalian 
gastrointestinal tract. 
 
 
 
Figure 1. Commensal bacteria in the mammalian GI tract can be classified by their anatomical 
localization as (i) luminal, (ii) epithelial-associated or (iii) lymphoid tissue-resident. Commensal 
bacteria are important for promoting normal host physiology. In the healthy mammals, most 
commensal bacteria occupy the lumen of the intestine while some are found associated with the 
intestinal epithelium. Recent studies have identified that commensal bacteria can also inhabit gut-
associated lymphoid tissues in the steady state. 
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Figure 2. Interactions between the host immune system and luminal 
commensal bacteria. 
 
Figure 2. Luminal commensal bacteria comprise of the majority of commensal bacteria in the 
mammalian intestine and are physically separated from immune cells. Colonization of the GI tract 
by luminal commensal bacteria promotes tissue protective and inhibits pathological immune 
responses. Anatomical containment of luminal commensal populations is mediated by physical 
and biochemical barriers such as IECs, tight junctions, mucus, antimicrobial peptides (AMPs) and 
secretory immunoglobulin A.  
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Figure 3. Interactions between the host immune system and intestinal 
epithelial-associated commensal bacteria. 
 
 
 
 
Figure 3. Colonization of the mammalian GI tract by epithelial-associated commensal bacteria 
promotes pro-inflammatory immune responses and is regulated by distinct host mechanisms. 
SFB is a model epithelial-associated commensal bacterium that colonizes the small intestine by 
adhering to IECs. SFB can promote pro-inflammatory immune responses that are associated with 
both pathogen immunity and autoimmunity. Some members of the luminal commensal flora such 
as B. fragilis and Clostridia can also colonize the epithelial surface of the colon and may interact 
with IECs.  
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Figure 4. Interactions between the host immune system and lymphoid 
tissue-resident commensal bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Lymphoid-tissue resident commensal bacteria can colonize gut-associated lymphoid 
tissues such as Peyer’s patches, isolated lymphoid follicles and mesenteric lymph nodes. 
Lymphoid tissue-resident commensal bacteria share many properties: they are typically aerobic, 
environmental microbes that are broadly resistant to antibiotics. One member of this group, 
Alcaligenes spp., is a potent inducer of intestinal IgA responses. Anatomical containment of 
Alcaligenes spp. is mediated by IL-22-producing RORγt+ innate lymphoid cells. Loss of this 
pathway results in dissemination of Alcaligenes spp., systemic inflammation and tissue pathology. 
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Figure 5. Regulation of iron homeostasis by the hormone hepcidin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Hepcidin is a iron-regulatory hormone that is expressed primarily by hepatocytes. 
Hepcidin interacts with the membrane-bound iron exporter, ferroportin (FPN) expressed on 
duodenal enterocytes, splenic macrophages and hepatocytes and results in its degradation. 
Hepcidin-ferroportin interactions therefore regulate plasma iron levels by inhibiting dietary iron 
absorption and iron release by splenic macrophages and hepatocytes. Expression of hepcidin is 
upregulated by plasma iron and inflammatory cytokines and downregulated by erythropoiesis. 
Figure modified from Ganz and Nemeth 2012 Biochimica et Biophysica Acta. 
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Figure 6. Role of iron homeostasis in host-pathogen interactions. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Iron is an essential nutrient for both mammals and microbial pathogens. Regulation of 
systemic iron levels by hepcidin differentially influences the survival and growth of extracellular 
and intracellular pathogens. In the absence of hepcidin expression where iron export by 
ferroportin (FPN) is uninhibited, increase in extracellular iron levels favors the growth of 
extracellular pathogens but may inhibit infection by intracellular pathogens. In the presence of 
hepcidin expression where iron export by ferroportin is inhibited, an increase in intracellular iron 
levels now favors growth of intracellular pathogens but inhibits infection by extracellular 
pathogens. 
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Chapter 2 
Lymphoid tissue-resident commensal bacteria colonize DCs and promote 
tissue-specific immune cell responses 
 
2.1 Abstract 
Dysregulated immune responses against commensal bacteria are associated 
with the pathogenesis of chronic inflammatory diseases, and can be prevented 
by maintaining physical separation between commensal bacteria and intestinal 
immune cells. However, recent reports demonstrate that selective species of 
commensal bacteria can reside within intestinal-associated lymphoid tissues of 
healthy mammals. How this unique colonization occurs and functionally 
influences the immune system is unclear. This Chapter will demonstrate that 
lymphoid tissue-resident commensal bacteria (LRC) can colonize and persist in 
murine dendritic cells and modulate their cytokine production. In germ-free and 
antibiotic-treated (ABX) mice, LRCs colonize intestinal-associated lymphoid 
tissues and induce multiple members of the IL-10 cytokine family, including 
dendritic cell-derived IL-10 and group 3 innate lymphoid cell (ILC3)-derived IL-22. 
Unlike SFB, which colonize the epithelial surface of the small intestine and 
promote lamina propria Th17 cell responses, LRCs selectively promote Th17 cell 
responses in the Peyer’s patch and mesenteric lymph nodes but not in the small 
intestine lamina propria. Collectively, the data in this Chapter reveal a novel host-
commensal bacteria dialogue whereby LRCs colonize intestinal-associated 
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lymphoid tissues and interact with dendritic cells to promote tissue-specific 
immune responses. 
 
2.2 Introduction 
Trillions of microorganisms constitutively colonize the mammalian gastrointestinal 
(GI) tract and are essential to establish and maintain a state of health (Belkaid 
and Hand, 2014; Turnbaugh et al., 2007). These microorganisms include 
commensal bacteria that aid in nutrient metabolism and resistance to pathogen 
infection (Brestoff and Artis, 2013; Buffie and Pamer, 2013; Flint et al., 2012), as 
well as the development and maturation of the immune system (Belkaid and 
Hand, 2014; Honda and Littman, 2012; Hooper et al., 2012; Ivanov and Honda, 
2012). In the healthy intestine, most commensal bacteria are restricted to the 
lumen of the GI tract or found associated with the surface of the intestinal 
epithelium and remain physically separated from the immune cells that populate 
the lamina propria and intestinal-associated lymphoid tissues (Chow et al., 2010; 
Chu and Mazmanian, 2013; Hooper et al., 2012; Hooper and Macpherson, 
2010). Physical separation of commensal bacteria from immune cells is achieved 
by multiple physical and biochemical mechanisms that include intestinal epithelial 
cells, tight junction proteins, and secretion of anti-microbial peptides, mucus and 
immunoglobulin A (Chow et al., 2010; Chu and Mazmanian, 2013; Hooper et al., 
2012; Hooper and Macpherson, 2010). Anatomical segregation of commensal 
bacteria from the immune system, often referred to as the “demilitarized zone”, is 
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essential to prevent pathologic immune responses against commensal bacteria 
(Hooper et al., 2012; Hooper and Macpherson, 2010). Consistent with this, 
translocation and dissemination of commensal bacteria across the intestinal 
epithelium lead to the generation of pro-inflammatory immune cell responses and 
are often associated with the pathogenesis of chronic infectious, inflammatory 
and metabolic diseases (Brenchley and Douek, 2012; Brenchley et al., 2006; 
Kamada et al., 2013; Loh and Blaut, 2012; Manichanh et al., 2012; Musso et al., 
2011; Zhao, 2013).  
Several recent studies suggest that a subset of commensal bacteria can 
colonize the interior of intestinal-associated lymphoid tissues of healthy 
mammals (Fung et al., 2014; Kunisawa and Kiyono, 2012; Obata et al., 2010; 
Sato et al., 2013; Sonnenberg et al., 2012). One report demonstrated by 16S 
rDNA sequencing and fluorescence in situ hybridization (FISH) that the interior of 
isolated lymphoid follicles (ILFs), Peyer’s patches (PPs) and mesenteric lymph 
nodes (mLNs) from healthy mice, non-human primates and humans contain 
multiple groups of bacteria (Obata et al., 2010). These bacteria include 
Alcaligenes spp., Achromobacter spp., Bordetella spp. and Ochrobactrum spp. 
16S rDNA for many of these lymphoid tissue-resident commensal bacteria 
(LRCs) were found associated with CD11c+ dendritic cells (DCs), suggesting a 
role for DCs in lymphoid tissue colonization. In a subsequent study, it was 
demonstrated that IL-22 and group 3 innate lymphoid cells (ILC3) are important 
in preventing systemic dissemination of one LRC, Alcaligenes xylosoxidans, and 
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subsequent induction of systemic inflammation (Sonnenberg et al., 2012). These 
data highlight that intestinal-associated lymphoid tissues are potential sites for 
colonization by commensal bacteria and innate immune pathways maintain 
anatomical segregation between LRCs and the systemic immune system. 
Despite these findings, the mechanisms by which commensal bacteria colonize 
immune cell-rich lymphoid compartments associated with the intestinal tract of 
healthy mammals, and the functional significance of this colonization to the host, 
remain undefined. This Chapter will demonstrate that lymphoid tissue-resident 
commensal bacteria can colonize the intracellular compartment of murine DCs, 
modulate DC cytokine production in a viability-dependent manner and promote 
local Th17 cell and ILC3 responses in intestinal-associated lymphoid tissues in 
vivo.  
 
2.3 Methods 
 
2.3.1 Mice 
C57BL/6 and Rag1-/- mice were purchased from Jackson Laboratories and used 
at 6-12 weeks of age. Conventional mice used as controls in gnotobiotic mice 
experiments were purchased from Jackson Laboratories and co-housed with 
mice bred in our conventional animal facility for at least 7 days before use. 
C57BL/6 and Rag1-/- mice used as controls for knockout mice were either bred in 
the same animal facility as the knockout mice, purchased from Jackson 
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Laboratories and co-housed with mice bred in our SPF animal facility for at least 
7 days or littermates as indicated to control for microbiota differences. All 
conventional mice were maintained in specific pathogen-free facilities at the 
University of Pennsylvania or Weill Cornell Medical College. Germ-free and 
gnotobiotic C57BL/6 and Rag1-/- mice were maintained within sterile vinyl 
isolators at the University of Pennsylvania or Weill Cornell Medical College 
Gnotobiotic Mouse Facility and monitored for germ-free or gnotobiotic status by 
aerobic and anaerobic culturing. Additional microbiology testing was performed 
on feces from mice under experimentation and at the endpoint of the experiment 
to confirm germ-free or monocolonization status. Germ-free C57BL/6 mice were 
monocolonized with the mouse LRC isolate Bordetella spp., or SFB by oral 
gavage or cohousing with soiled bedding from previously monocolonized mice for 
at least 10 days. To establish LRC colonization in ABX-treated mice, 
conventional mice were treated in the drinking water with a limited ABX cocktail 
of ampicillin (1 mg/ml, Sigma) and gentamicin (1 mg/ml, Gemini Bio-Products) for 
C57BL/6 mice or ampicillin (1 mg/ml), gentamicin (1 mg/ml) and neomycin (0.25 
mg/ml, Sigma) for Rag1-/- for 3 days and then orally gavaged with the clinical 
LRC isolate (LRCR), Achromobacter. Antibiotic cocktails were supplemented with 
1 packet of artificial sweetener (Sweet’N Low) per 250 ml. All mice were used at 
least 10 days post LRCR colonization. All experiments were performed according 
to the guidelines of the University of Pennsylvania or Weill Cornell Medical 
College Institutional Animal Care and Use Committee. 
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2.3.2 Microbiology 
The LRC strain, Bordetella spp., used to colonize BMDCs or monocolonize germ-
free mice was originally isolated from the spleen of an anti-CD90.2 mAb treated 
conventional Rag1-/- mice using a previously defined protocol (Sonnenberg et al., 
2012). E. coli (human isolate) and Ochrobactrum spp. used to colonize BMDCs 
and the ABX-resistant (ampicillin, gentamicin, neomycin) LRC (LRCR), 
Achromobacter used to colonize antibiotic-treated mice were human clinical 
isolates kindly provided by Kaede V. Sullivan (Children’s Hospital of 
Philadelphia). Bacterial identities were determined by genomic sequencing 
(Wellcome Trust Sanger Institute) and confirmed by genus-specific 16S rDNA 
primers. E. coli R9 (ATCC 35328), Enterobacter cloacae (ATCC 13047) and 
gentamicin-sensitive Achromobacter spp. (ATCC 31444) used to colonize 
BMDCs were purchased from American Type Culture Collection. Feces from 
SFB-monocolonized mice were obtained from Dr. Yoshinori Umesaki and Dr. 
Tatsuichiro Shima (Yakult). All bacterial strains used to colonize germ-free mice 
and for in vitro DC assays were grown in LB broth and incubated at 250 RPM, 
37°C for 16-20 hours. For enumeration of tissue and fecal CFUs, the spleen, 
liver, feces, mesenteric lymph nodes (mLN) and Peyer’s patches (PP) were 
isolated, homogenized in sterile PBS and plated on Brain Heart Infusion (BHI) 
agar supplemented with 5% defibrinated horse blood. When culturing LRCR from 
tissues and feces, BHI blood agar plates were supplemented with 25 µg/ml 
ampicillin.  
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2.3.3 Bone marrow-derived and primary dendritic cell assays 
Bone marrow-derived DCs were generated by culturing bone marrow cells from 
C57BL/6, Myd88-/-, Tlr2-/- and Tlr4-/- mice in the presence of 20 ng/mL GM-CSF 
for 8-10 days. Culture media was replaced with fresh media every 3 days. 
Frequencies of CD11c+ cells were ≥ 95%. To prepare primary splenic and mLN 
DCs, C57BL/6 mice were first injected subcutaneously in the right flank with 5 x 
106 cells GM-CSF-expressing B16 melanoma (kindly provided by Jedd D. 
Wolchok, MSKCC). 10 days later, CD11c+ cells were purified from Liberase TL 
(Roche)-digested spleen and mLN using CD11c positive selection beads 
(Miltenyi Biotec). Cell purities in the spleen were approximately 90% CD11c+ 
CD11b+ of non-T and B cells. For intracellular bacterial survival assays, BMDCs 
were seeded on 6-well plates at 5 x 106 cells/well in antibiotic-free media and co-
cultured with bacteria at an MOI of 50 for 2 hours, harvested and washed 3 times 
with sterile PBS. BMDCs were then plated in media containing gentamicin (100 
µg/mL) at 200,000 cells/well on 48-well plates and lysed with sterile water every 
48 hours to enumerate CFUs. For ELISA and qPCR, BMDCs were co-cultured 
with bacteria at an MOI of 50 for 2 hours and then gentamicin-treated to kill 
extracellular bacteria. Culture supernatants and cell lysates were harvested for 
ELISA and qPCR, respectively, 24 hours later. Heat killing was performed by 
incubating bacterial suspensions at 70°C for 60 min. For transmission electron 
microscopy, BMDCs colonized with Bordetella spp. for 5 days were harvested, 
processed for imaging by the University of Pennsylvania Electron Microscopy 
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Resource Laboratory and imaged using the Jeol-1010 transmission electron 
microscope. For microarray analysis, BMDCs were co-cultured with bacteria for 2 
hours, washed extensively with PBS, incubated in media containing gentamicin 
(100 µg/mL) and lysed in TRIzol on day 4. All cell incubations were performed at 
37°C and 5% CO2. 
 
2.3.4 Immunofluorescent detection of intracellular bacteria 
BMDC-bacteria co-cultures were harvested on days 0, 2 and 5 and transferred to 
glass slides via cytospin. BMDCs were fixed with 4% PFA for 30 minutes at room 
temperature and stained with the Live/Dead BacLight Bacterial Viability Kit 
according to the manufacturer’s instructions (Invitrogen). Cells were mounted 
with VectaShield mounting medium containing DAPI (Vector Laboratories) and 
imaged on the Nikon Eclipse Ti Fluorescence Inverted Microscope. PFA fixation 
did not affect the ability of the bacterial viability kit to distinguish between live and 
dead bacteria. 
 
2.3.5 Gene expression profiling and quantitative real-time PCR 
RNA was isolated using TRIzol reagent (Life Technologies) according to the 
manufacturer’s instructions. cDNA was generated using Superscript reverse 
transcriptase II (Invitrogen). Quantitative real-time PCR was performed using 
SYBR green chemistry (Invitrogen) and QuantiTect Primer Assays (Qiagen) on 
the ABI 7500 real-time PCR system (Applied Biosystems). Samples were 
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normalized to β-actin and displayed as fold change over PBS-treated BMDCs or 
antibiotic-treated mice. For microarray analysis, BMDCs colonized with the LRC, 
Bordetella spp., for 4 days were lysed directly in TRIzol. RNA was isolated, 
amplified, reverse-transcribed to cDNA and hybridized to an Affymetrix GeneChip 
(Mouse Gene 1.0ST) by the University of Pennsylvania Molecular Profiling 
Facility. Relative expression data was normalized by Z score transformation. 
 
2.3.6 Flow cytometry 
mLN and PP were harvested, and single-cell suspensions were prepared at 
necropsy. For small intestine lamina propria preparations, intestines were 
isolated, attached fat and PPs were removed and tissues were cut open 
longitudinally. Luminal contents were removed by shaking in cold PBS. Epithelial 
cells and intra-epithelial lymphocytes were removed by shaking tissue in stripping 
buffer (1 mM EDTA, 1 mM DTT and 5% FCS) at 37°C for 30 minutes. The lamina 
propria layer was isolated by digesting the remaining tissue in 1 mg/mL 
collagenase/dispase (Roche) and 20 µg/mL DNase I (Sigma-Aldrich) for 30 
minutes at 37°C. For flow cytometric analyses, cells were stained with antibodies 
against the following markers: anti-NK1.1 (clone PK136, eBioscience), anti-CD3 
(clone 145-2C11, eBioscience), anti-CD5 (clone 53-7.3, eBioscience), anti-
CD11c (clone N418, eBioscience), anti-CD4 (clone GK1.5, Abcam), anti-CD8α 
(clone 53-6.7, eBioscience), anti-B220 (clone RA3-6B2, eBioscience), anti-CD45 
(clone 30-F11, eBioscience) and anti-CD11b (clone M1/70, eBioscience). For 
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intracellular staining of RORγt, cells were fixed and permeabilized with the Foxp3 
intracellular staining buffer set (eBioscience) and stained with anti-RORγt (clone 
B2D, eBioscience). For intracellular cytokine staining, cells were stimulated ex 
vivo by incubation for 4 h with 50 ng/mL PMA, 750 ng/mL ionomycin, 10 µg/mL 
Brefeldin A (all obtained from Sigma-Aldrich) and 50 ng/mL rmIL-23 
(eBioscience) and permeabilized as indicated above and stained with anti-IL-17A 
(clone eBioTC11-18H10.1, eBioscience), anti-IFN-γ (clone XMG1.2, 
eBioscience) and anti-IL22-02 (mouse cytokine detection antibody developed by 
Pfizer). Dead cells were excluded from analysis using the Live/Dead Aqua 
Viability Kit (Invitrogen). Flow cytometry data collection was performed on the 
LSR II (BD Biosciences). Data were analyzed using FlowJo software (Tree Star 
Inc.).   
 
2.3.7 Histology 
Tissues from the small and large intestines were fixed with 4% PFA, embedded 
in paraffin, and 5 µm sections were cut and stained with H&E. 
 
2.3.8 Bacterial genome sequencing, assembly, and annotation.  
DNA was prepared and sequenced using the Illumina Hi-Seq platform with library 
fragment sizes of 200-300 bp and a read length of 100 bp at the Wellcome Trust 
Sanger Institute, as previously described (Harris et al., 2010). De novo assembly 
of 32 genomes was performed with Velvet v. 1.2.10 (Zerbino and Birney, 2008), 
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SSPACE v. 2.0 (Boetzer et al., 2011) and GapFiller v 1.1 (Boetzer and Pirovano, 
2012) using an in-house pipeline developed at the Wellcome Trust Sanger 
Institute. De novo assemblies were annotated with Prokka v. 1.5-1 (Seemann, 
2014) using an in-house pipeline developed at the Wellcome Trust Sanger 
Institute, which is available on GitHub (https://github.com/sanger-pathogens/Bio-
AutomatedAnnotation).  
 
2.3.9 Phylogenetic analysis 
The fetchMG v. 1.0 (http://www.bork.embl.de/software/mOTU/fetchMG.html) was 
used to extract the protein information based on 40 universal single copy marker 
genes (Ciccarelli et al., 2006; Sorek et al., 2007) from each of the studied 
genome including 32 draft genomes and 15 reference genomes (Table S1). The 
protein sequences were then concatenated and aligned with MAFFT v. 7.205 
(Katoh and Standley, 2013), and a maximum-likelihood tree was constructed 
using RAxML v. 7.8.6 (Stamatakis, 2006) with 100 bootstrap replicates under the 
Gamma + WAG model. The tree was visualized using SplitsTree v. 4.13.1 
(Huson and Bryant, 2006). 
 
2.3.10 Statistical analyses 
Results represent mean ± SEM and statistical analyses were performed by 
unpaired student’s t-test, one- or two-way ANOVA with or without multiple 
comparisons tests as indicated in figure legends. 
 60 
2.3.11 Data accessibility 
Sequenced microbial genome data have been deposited in the European 
Nucleotide Archive under study number ERP012121.  Array data have been 
deposited in GEO under accession number GSE76731. 
 
2.4 Results 
 
2.4.1 Lymphoid tissue-resident commensal bacteria are phylogenetically 
distinct from luminal commensal bacteria 
16S rDNA for several groups of bacteria have been detected in the interior of 
PPs and the mLN of healthy mice (Obata et al., 2010; Sonnenberg et al., 2012). 
These LRCs, including Achromobacter spp., Alcaligenes spp., Bordetella spp. 
and Ochrobactrum spp., belong exclusively to the α- and β-proteobacteria 
groups, which are not highly represented in sequence analyses of the luminal 
contents of the intestine (Eckburg et al., 2005; Hill et al., 2010; Ley et al., 2005; 
Ley et al., 2006). We constructed a phylogenetic tree using in-house sequenced 
and publically available reference genomes of α-, β-, γ-proteobacteria and 
Bacteroidia members (Table 1). Phylogenetic analyses indicated that members 
of the α-proteobacteria and β-proteobacteria LRCs form two distinct clades from 
γ-proteobacteria and Bacteroidia members, which are typically found in the 
lumen of the intestine and not associated with intestinal lymphoid tissues in 
healthy mammals (Figure 7A). 
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2.4.2 Lymphoid tissue-resident commensal bacteria colonize the 
intracellular compartment of murine dendritic cells in vitro 
16S rDNA for LRCs have been detected in CD11c+ cells from PPs and the mLN 
of healthy mice (Obata et al., 2010; Sonnenberg et al., 2012), suggesting LRCs 
may colonize DCs. To test this, bone marrow-derived DCs (BMDCs) were co-
cultured with intestinal bacteria predicted to be LRCs or representative intestinal 
microbes not predicted to be LRCs (non-LRCs), and the ability of each bacterium 
to survive in DCs was determined using a gentamicin protection assay. LRCs 
and non-LRCs were both internalized by DCs, but the numbers of viable non-
LRCs declined rapidly within the first three days of culture, while viable LRCs 
persisted at high levels on days 2 and 4 (Figure 7B). LRCs but not non-LRCs 
were also able to colonize and persist in primary DCs isolated from the mLN and 
spleen (Figure 7C and 7D). Transmission electron microscopy (TEM) 
demonstrated intracellular colonization of DCs by LRCs as noted by the 
presence of dense bacterial clusters within intracellular vesicles (Figure 8A). To 
investigate the kinetics of intracellular survival of LRCs on a single-cell level, LRC 
and non-LRC-colonized BMDCs were analyzed using an immunofluorescence 
assay that distinguishes between live and dead bacteria. Both LRCs and non-
LRCs were able to initially colonize BMDCs, however, the number of BMDCs 
containing viable bacteria was significantly greater for LRC-colonized BMDCs on 
days 2 and 5 (Figure 8B and 8C). Similar to the results using TEM, LRCs appear 
to form dense clusters in BMDCs beginning at day 2 post-colonization. However, 
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these clusters were not observed in non-LRC-colonized DCs (Figure 8B). 
Together, these data suggest that, in contrast to luminal-resident commensal 
bacteria, LRCs have the ability to efficiently colonize and persist in murine DCs. 
 
2.4.3 Lymphoid tissue resident-commensal bacteria modulate dendritic cell 
cytokine production in a viability- and TLR-dependent manner 
Innate immune cells such as DCs and macrophages respond to microbial stimuli 
by producing pro- and anti-inflammatory cytokines that shape subsequent 
adaptive immune cell responses. In the intestine, these responses are critical in 
regulating tissue homeostasis, immunity and inflammation (Bekiaris et al., 2014; 
Coombes and Powrie, 2008; Rescigno, 2010). Furthermore, DCs and 
macrophages can sense viability-associated molecular patterns in bacteria to 
induce distinct cytokine responses (Sander et al., 2011). Based on the ability of 
LRCs to colonize and persist in murine DCs, we sought to characterize DC 
cytokine induction following exposure to live versus heat-killed LRCs. To begin to 
test this, genome-wide transcriptional profiling was performed on DCs treated 
with PBS, live or heat-killed Bordetella spp., a model LRC isolated from our 
mouse colony, at 4 days post-exposure. Analysis of canonical DC-derived 
cytokines revealed that DCs colonized with live LRCs expressed greater levels of 
the pro- and anti-inflammatory cytokines Il6, Il23a, Il18, Il12a, Il12b, Il10 and 
Tgfb2 compared to PBS-treated DCs (Figure 9A). Notably, the induction of 
mRNA and protein for several of these cytokines, including IL-1β, IL-6, IL-10, IL-
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12p40 and IL-23, by live LRCs was detected as early as 24 hours post co-culture 
(Figure 9B and 9C), and the induction of IL-10 and IL-23 mRNA (Figure 9A and 
9B) and secretion of IL-1β, IL-10 and IL-23 protein (Figure 9C) did not occur in 
DCs exposed to only heat-killed LRCs, suggesting that viability-dependent 
factors expressed by LRCs induce selective DC cytokine responses. Primary 
splenic DCs exposed to live LRCs also produced IL-1β, IL-6, IL-10 and IL-12p40 
(Figure 9D). Efficient induction of both viability- (IL-1β, IL-10, IL-23) and non-
viability-dependent cytokines (IL-6, IL-12p40) required MYD88, suggesting a role 
for Toll-like receptors (TLRs) in recognition of LRCs (Figure 10A). Consistent with 
this, production of IL-1β and IL-23 was significantly reduced in Tlr4-/- but not Tlr2-
/- BMDCs (Figure 10B). Collectively, these data indicate that LRCs can effectively 
colonize murine DCs in vitro and promote distinct pro- and anti-inflammatory 
cytokine responses by DCs in a viability- and TLR-dependent manner. 
 
2.4.4 Lymphoid tissue-resident commensal bacteria colonize intestinal-
associated lymphoid tissues in gnotobiotic mice 
Most commensal bacteria found in the intestine are restricted to the lumen or the 
surface of the intestinal epithelium (Chow et al., 2010; Chu and Mazmanian, 
2013; Hooper et al., 2012; Hooper and Macpherson, 2010). However, 16S rDNA 
for multiple groups of bacteria are enriched in the ILFs, PPs and mLN of healthy 
mice (Obata et al., 2010; Sonnenberg et al., 2012). To test whether these LRCs 
can stably colonize and survive in intestinal-associated lymphoid tissues, germ-
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free mice were monocolonized with Bordetella spp., a model LRC isolated from 
our mouse colony. At day 10 post-inoculation, viable LRCs were consistently 
detected in the mLN (Figure 11A), PPs (Figure 11B) and fecal contents of the 
small intestinal lumen (Figure 11C), but not the spleen and liver. However, 
colonization by LRCs was not associated with macroscopic or microscopic 
inflammation in the intestine at 2 weeks post colonization (Figure 11D). These 
data support the hypothesis that LRCs can colonize and persist in intestinal-
associated lymphoid tissues of healthy mammals. 
 
2.4.5 Lymphoid tissue-resident commensal bacteria promote tissue-
specific Th17 cell responses in gnotobiotic mice 
Commensal bacteria modulate the innate and adaptive immune system in the GI 
tract (Belkaid and Hand, 2014; Honda and Littman, 2012; Hooper et al., 2012; 
Ivanov and Honda, 2012). Based on the ability of live LRCs to elicit IL-1β, IL-6, 
IL-23 and TGFβ, which are potent enhancers of Th17 cell responses (Korn et al., 
2009), we hypothesized that LRCs may promote Th17 cell responses in 
colonized lymphoid tissues. To test this, we analyzed CD4+ T cells in the PP, 
mLN and small intestine lamina propria (SI LP) of conventionally-housed (CNV), 
germ-free, LRC-monocolonized mice and mice monocolonized with segmented 
filamentous bacteria (SFB), an epithelial-associated commensal bacterium which 
has previously been shown to induce robust Th17 cell responses in the SI LP 
(Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009). Consistent with published 
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reports, germ-free mice lacked Th17 cells in the mLN (Figure 12A), PP (Figure 
12B) and SI LP (Figure 12C) compared to CNV mice, and SFB was sufficient to 
promote robust Th17 cell responses in all three of these tissues. In contrast, 
LRCs promoted Th17 cell responses in the mLN and PP (Figure 12A, 12B and 
12D) but failed to promote Th17 cell responses in the SI LP (Figure 10C and 
10D), suggesting tissue-specific modulation of the immune system. Analysis of 
LRC-elicited Th17 cells in the PP revealed that a subset of these cells co-
expressed the IL-10 family cytokine, IL-22 (Figure 13A and 13B). Accumulation 
of Th17 cells was selective as compared to Th1 cells, since LRCs did not 
significantly promote IFNγ-producing CD4+ T cell responses in the mLN, PP or SI 
LP (Figure 13C). Collectively, these data indicate that LRCs selectively promote 
Th17 cell responses at intestinal-associated lymphoid tissues. 
 
2.4.6 Lymphoid tissue-resident commensal bacteria promote tissue-
specific ILC3 responses in gnotobiotic mice 
ILC3 also respond to the cytokines IL-1β, IL-6 and IL-23, express the 
transcription factor RORγt, and have important functions in lymphoid tissue 
organogenesis, immunity to pathogens and intestinal tissue homeostasis through 
production of effectors cytokines IL-17A and IL-22 (Artis and Spits, 2015; 
Diefenbach et al., 2014; McKenzie et al., 2014; Qiu and Zhou, 2013; Sonnenberg 
and Artis, 2012, 2015). Based on the ability of live LRCs to elicit DC-derived IL-
1β, IL-6 and IL-23, we hypothesized that LRCs may promote ILC3 responses in 
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intestinal-associated lymphoid tissues. To test this, we measured ILC3 
frequencies in the PP, mLN and SI LP of CNV, germ-free, SFB-monocolonized 
and LRC-monocolonized mice. Consistent with published reports, germ-free mice 
have reduced frequencies of ILC3 in the SI LP as compared to CNV mice (Klose 
et al., 2013; Satoh-Takayama et al., 2008). Monocolonization by SFB did not 
significantly alter ILC3 frequencies in the PP, mLN and SI LP (Figure 14A-D). In 
contrast, LRC-monocolonized mice revealed a significant increase in ILC3 
frequencies in the PP and mLN (Figure 14A, 14B and 14D) but not in the SI LP 
as compared to germ-free mice (Figure 14C and 14D). Notably, ILC3s in the PP 
of LRC-monocolonized mice produced IL-22 (Figure 15A). However, frequencies 
and total numbers of IL-22+ ILC3 were comparable between germ-free and LRC-
colonized mice (Figure 15B). Collectively, these data suggest that LRCs 
modulate tissue-specific ILC3 responses in the intestine. 
 
2.4.7 Lymphoid tissue-resident commensal bacteria colonize intestinal-
associated lymphoid tissues in antibiotic-treated mice 
ILC3 and IL-22 responses induce anti-microbial proteins in the intestine (Artis 
and Spits, 2015; Diefenbach et al., 2014; McKenzie et al., 2014; Rutz et al., 
2013; Sonnenberg and Artis, 2012, 2015; Sonnenberg et al., 2011), suggesting 
that LRCs may induce immune responses that limit its own colonization or the 
colonization of other bacteria. To investigate the role of LRC-elicited immune 
responses in LRC-host interactions, we established a mouse model of LRC 
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colonization by treating conventional C57BL/6 mice with a limited cocktail of 
antibiotics (ABX) followed by inoculation with an antibiotic-resistant LRC, 
Achromobacter (LRCR). We confirmed that, similar to the results using LRC-
monocolonized mice, LRCR could be cultured from the mLN and PPs of LRCR-
colonized C57BL/6 mice in which LRCR was the dominant bacterial species in 
the intestinal lumen (Figure 16A and 16B). Furthermore, analyses of ILC3 
responses in LRCR-colonized C57BL/6 mice revealed a significant increase in IL-
22+ ILC3 frequencies as compared to ABX-treated controls (Figure 16D).  
Collectively, these data suggest that LRCs can colonize intestinal-associated 
lymphoid tissues not only in gnotobiotic but also in antibiotic mice. 
 
2.4.8 Lymphoid tissue-resident commensal bacteria promote innate 
immune cell responses in a tissue-specific manner in antibiotic-treated 
mice 
Live LRCR were also detected in the mLN of LRCR-colonized Rag1-/- mice (Figure 
16C), suggesting that lymphoid tissue colonization does not require the adaptive 
immune system and allowing us to interrogate interactions between LRCs and 
the innate immune system. To investigate whether DC colonization and cytokine 
modulation by LRCs occur in the absence an adaptive immune system in vivo, 
we measured LRCR 16S rDNA and cytokine gene expression in CD11c+ cells 
isolated from the mLN of LRCR-colonized Rag1-/- mice. LRCR 16S rDNA was 
detected in CD11c+ cells from LRCR-colonized but not in control ABX-treated 
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mice (Figure 16E), suggesting that in this model LRCs or LRC-derived nucleic 
acids are associated with murine DCs isolated from lymphoid tissues of healthy 
mice. Furthermore, CD11c+ cells from LRCR-colonized mice expressed increased 
levels of Il1b, Il10 and Il23a as compared to CD11c+ cells from control ABX-
treated mice (Figure 17A). Induction of Il1b and Il23a was associated with an 
increase in Il17a and Il22 expression in the whole mLN but not the small intestine 
of LRCR-colonized Rag1-/- mice (Figure 17B and 17C). Altogether, these data 
demonstrate that LRCs modulate tissue-specific DC and ILC3 responses in 
antibiotic-treated mice. 
 
2.5 Discussion 
The findings in this Chapter define a unique host-commensal bacteria dialogue 
whereby direct interactions between LRCs and the mammalian immune system 
orchestrate tissue-specific immune responses. While most studies interrogating 
host-microbiota interactions to date have focused on populations of commensal 
bacteria residing in the intestinal lumen or attached to the intestinal epithelium, 
here we examine an under-appreciated class of commensal bacteria that has the 
potential to reside closely associated with immune cells in the interior of intestine-
associated lymphoid tissues. This colonization pattern is paradoxical to our 
current understanding of interactions between the immune system and 
commensal bacteria, which suggests that anatomical segregation must occur to 
limit the development of pathologic immune responses (Brenchley and Douek, 
 69 
2012; Hooper et al., 2012; Hooper and Macpherson, 2010; Kamada et al., 2013; 
Manichanh et al., 2012). The data from this Chapter identifying the 
immunological role of commensal bacteria colonization in lymphoid tissues 
represent a key advance in our understanding of host-commensal bacteria 
interactions. Furthermore, these studies suggest that ongoing host-microbiota 
studies should consider not only the composition of luminal and epithelial 
commensals but also commensal bacteria communities that colonize organized 
lymphoid tissues associated with the intestine such as the mLN, PPs and ILFs.  
 Interrogating interactions between the host immune system and several 
species of LRCs revealed that LRCs but not luminal members of the microbiota 
could colonize and persist within murine DCs and modulate selective DC 
cytokine responses in a viability-dependent manner. Induction of IL-1β, IL-6, IL-
10 and IL-23 by non-LRCs such as E. coli has been demonstrated by other 
groups (Hayashi et al., 2013; Manuzak et al., 2012; Sander et al., 2011), 
suggesting that activation of DCs does not account for differences in intracellular 
bacterial survival. Constitutive colonization of intestinal DCs by LRCs likely 
maintains expression of viability-dependent cytokines, including IL-1β, IL-10 and 
IL-23. This is in direct contrast to luminal-resident or epithelial-attached 
commensal bacteria in which viable bacteria belonging to these groups are not 
typically found beyond the intestinal epithelium (Hooper et al., 2012; Hooper and 
Macpherson, 2010; Obata et al., 2010). Therefore, these commensal bacteria 
predominantly influence immune cells through indirect interactions, for example 
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via production of metabolites or modulation of intestinal epithelial cell responses 
(Arpaia et al., 2013; Furusawa et al., 2013; Goto et al., 2014; Ivanov et al., 2009; 
Pham et al., 2014; Pickard et al., 2014; Smith et al., 2013). It is likely that LRCs 
may provide more direct and continuous stimulation to the immune system. 
Furthermore, the data in this Chapter suggest that induction of tissue-specific 
immune responses by commensal bacteria is linked to their anatomical 
localization in the GI tract and associated lymphoid tissues. Consistent with this, 
the epithelial-associated commensal SFB, induces potent SI LP Th17 cell 
responses that are dependent primarily on physical attachment to intestinal 
epithelial cells, production of epithelial cell-derived SAA1/2 and activation of the 
IL-23R-IL-22 axis. (Atarashi et al., 2015; Gaboriau-Routhiau et al., 2009; Ivanov 
et al., 2009; Sano et al., 2015). Similarly, Bacteroides fragilis predominantly 
colonizes the colonic crypts in mice and promotes robust regulatory T cell 
responses in the underlying colon lamina propria (Lee et al., 2013; Round and 
Mazmanian, 2010). This Chapter demonstrates that LRCs colonize and activate 
DCs to selectively promote Th17 cell and ILC3 responses within intestinal-
associated lymphoid tissues.  
 Collectively, the findings in Chapter 2 demonstrate that colonization of 
lymphoid tissues by commensal bacteria modulates the host immune system in a 
tissue-specific manner. Further interrogation of LRC colonization in health and 
disease will be critical to understand the complex microbial contexts where LRCs 
influence tissue immunity and inflammation. Understanding the mechanisms by 
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which LRCs modulate tissue-specific immune cell function may inform the 
development the therapeutics for the treatment of chronic inflammatory diseases. 
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Figure 7. Lymphoid tissue-resident commensal bacteria are 
phylogenetically distinct from luminal commensal bacteria and selectively 
colonize murine dendritic cells. 
 
 
Figure 7. (A) Maximum-likelihood tree of 47 bacterial genomes based on 40 universal single copy 
marker genes. Red symbols indicate published reference genomes. Blue symbols and text 
indicate in-house sequenced genomes. Scale bar indicates number of substitutions per site. (B) 
Bone marrow-derived dendritic cells (BMDCs) were co-cultured with representative LRCs or 
luminal-resident commensals and bacterial survival was measured at 0, 48 and 96 hours. Data 
are representative of at least 2 independent experiments. (C) Primary DCs isolated from the 
mesenteric lymph node (mLN) and (D) spleen of C57BL/6 mice were co-cultured with the mouse-
derived LRC, Bordetella spp. or luminal commensal, E. coli ATCC 35328, and bacterial survival 
was measured at 0, 48 and 96 hours. l.o.d., limit of detection. Data are representative of 2 
independent experiments. 
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Figure 8. Lymphoid tissue-resident commensal bacteria colonize the 
intracellular compartment of bone marrow-derived dendritic cells.  
 
 
Figure 8. (A) Bordetella-colonized BMDCs were analyzed at day 5 post co-culture by 
transmission electron microscopy. Images are representative of 10 individual bacteria-containing 
DCs. (B) Bordetella- and E. coli-colonized BMDCs were analyzed at day 0, 2 and 5 post-co-
culture by immunofluorescence. Scale bar – 5 µm. Data are representative of 2 independent 
experiments. (C) Percentage of BMDCs containing live (green) bacteria was quantified across 7-
16 distinct fields of view. Infection efficiency (BMDCs containing live or dead bacteria/total 
BMDCs) on day 0 was approximately 15% for Bordetella spp. and 30% for E. coli. Data are 
represented as mean ± SEM. Statistics were performed using unpaired, two-tailed, student’s t 
test. ***, p < 0.0001. ND, not detectable.  
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Figure 9. Lymphoid tissue-resident commensal bacteria modulate dendritic 
cell cytokine responses in a viability-dependent manner.   
 
Figure 9. (A) Genome-wide transcriptional profiling was performed on BMDCs co-cultured with 
live or heat-killed Bordetella spp. for 4 days. Numbers in colored legend represent Z scores. (B) 
BMDCs co-cultured with live or heat-killed Bordetella spp. for 24 hours were analyzed for cytokine 
gene expression by qPCR. (C) BMDCs co-cultured with live or heat-killed Bordetella spp. for 24 
hours were analyzed for cytokine protein secretion by ELISA. (D) Production of IL-1β, IL-6, IL-10 
and IL-12p40 was measured in supernatants from Bordetella- or E. coli-spleen DC co-cultures at 
96 h post-co-culture. qPCR and ELISA data are representative of at least 2 independent 
experiments. Data are represented as mean ± SEM. Statistics in B and C were performed using 
unpaired, two-tailed, student’s t test. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.  
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Figure 10. Lymphoid tissue-resident commensal bacteria modulate 
dendritic cell cytokine production in a MYD88- and TLR-dependent manner.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. (A) C57BL/6 and Myd88-/- BMDCs were treated with PBS or co-cultured with 
Bordetella spp. for 24 hours and production of IL-1β, IL-6, IL-10, IL-12p40 and IL-23 was 
measured in the culture supernatant by ELISA. (B) C57BL/6, Tlr2-/- and Tlr4-/- BMDCs were 
treated with PBS or co-cultured with Bordetella spp. for 24 hours and production of IL-1β and IL-
23 was measured in the culture supernatant by ELISA. Data are representative of 2 independent 
experiments. Statistics were performed using two-way ANOVA with Sidak’s multiple comparisons 
test. ****, p < 0.0001. 
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Figure 11. Lymphoid tissue-resident commensal bacteria colonize 
intestinal-associated lymphoid tissues but do not cause pathological 
inflammation in gnotobiotic mice.  
 
 
Figure 11. (A) Mesenteric lymph node (mLN), (B) Peyer’s patch (PP) homogenates and (C) small 
intestinal lumen contents from GF and Bordetella spp. (LRC)-monocolonized mice were cultured 
to determine bacterial CFUs. Data in (A) and (B) are representative of at least 2 independent 
experiments. (D) H&E staining of the small intestine and colon of conventional (CNV), germ-free 
(GF) and mice LRC-monocolonized mice. 
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Figure 12. Lymphoid tissue-resident commensal bacteria promote tissue-
specific Th17 cell responses in gnotobiotic mice.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. (A) mLN, (B) PP and (C) small intestine lamina propria (SI LP) of conventionally-
housed (CNV), GF, SFB-monocolonized and LRC-monocolonized mice were analyzed for 
frequencies of IL-17A+ and IFNγ+ CD4+ T cells by flow cytometry. (D) Frequencies of Th17 cells in 
CNV, GF, SFB-monocolonized and LRC-monocolonized mice. Values represent frequencies of 
IL-17A+ cells among CD4+ T cells. One-way ANOVA, mLN and SI LP - ****p < 0.0001; PP - **p < 
0.01. Cells in all flow cytometry plots are gated as live, Lineage+ and CD4+. Lineage cocktail 
consists of CD3, CD5, CD8α, CD11b and NK1.1. Data are represented as mean ± SEM. Data 
are pooled from 2 independent experiments for a total of 6-8 mice per group. Statistics in D were 
performed using one-way ANOVA with unpaired, two-tailed, student’s t test with no correction for 
multiple comparisons. *, p < 0.05; **, p < 0.01; ****, p < 0.0001. 
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Figure 13. Lymphoid tissue-resident commensal bacteria promote tissue-
specific IL-22-producing Th17 cell responses in gnotobiotic mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. (A and B) PPs of CNV, GF, SFB-monocolonized and LRC-monocolonized mice were 
analyzed for frequencies of IL-22-producing Th17 cells by flow cytometry. Values represent 
frequencies of IL-22+IL-17A+ CD4+ T cells. One way ANOVA, mLN - ****p < 0.0001; PP - **p < 
0.01; SI LP - *p < 0.05. Data are pooled from 2 independent experiments for a total of 6-8 mice 
per group. (C) Frequencies of Th1 (IFNγ+ of Lineage+CD4+) cells in the mLN, PP and SI LP of 
CNV, GF and LRC-monocolonized mice. Lineage cocktail consists of CD3, CD5, CD8α, CD11b 
and NK1.1. One-way ANOVA, mLN - **p < 0.01; PP - ****p < 0.0001; SI LP - ***p < 0.001. Data 
representative of 3 independent experiments. Statistics in panel B were performed using one-way 
ANOVA with unpaired, two-tailed, student’s t test with no correction for multiple comparisons. 
Statistics in panel C were performed using one-way ANOVA with uncorrected Fisher’s LSD test. 
*, p < 0.05; **, p < 0.01; p < 0.001; ****, p < 0.0001. 
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Figure 14. Lymphoid tissue-resident commensal bacteria promote tissue 
specific ILC3 responses in gnotobiotic mice  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. (A) mLN, (B) PP and (C) SI LP of CNV, GF, SFB-monocolonized and Bordetella 
(LRC)-monocolonized mice were analyzed for frequencies of ILC3 cells by flow cytometry. Cells 
in (A) were gated as live and lineage- (CD3-, CD5-, CD8α, CD11b-, B220-, NK1.1-). Cells in (B) 
and (C) were gated as live, CD45+ and lineage-. (D) Quantification of ILC3 frequencies in the 
mLN, PP and SI LP of CNV, GF, SFB-monocolonized and LRC-monocolonized mice. mLN ILC3 
values represent frequencies of CD45+RORγt+ of lineage- cells. PP and SI LP ILC3 values 
represent frequencies of CD90+RORγt+ of lineage- cells. One-way ANOVA, mLN - ****p < 0.0001; 
PP - *p < 0.05; SI LP - **p < 0.01. Data are pooled from 2 independent experiments for a total of 
6-8 mice per group. Data are represented as mean ± SEM. Statistics in panel D were performed 
using one-way ANOVA with uncorrected Fisher’s LSD test. *, p < 0.05; **, p < 0.01; ***, p < 0.001. 
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Figure 15. Lymphoid tissue-resident commensal bacteria do not elicit IL-22-
producing ILC3 in gnotobiotic mice. 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. (A) PPs of CNV, GF, SFB-monocolonized and LRC-monocolonized mice were 
analyzed for frequencies of IL-22+ ILC3 cells by flow cytometry. Cells are gated as live, lineage-, 
CD90+ and RORγt+. Data are pooled from 2 independent experiments for a total of 6-8 mice per 
group. (B) Numbers of total or IL-22+ ILC3 in the mLN of CNV, GF, SFB-monocolonized and 
LRC-monocolonized mice. Data are representative of 2 independent experiments with 4-5 mice 
per group. Data are represented as mean ± SEM. 
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Figure 16. Lymphoid tissue-resident commensal bacteria colonize 
antibiotic-treated mice.   
 
 
Figure 16. Bacterial CFUs were determined in antibiotic (ABX)-treated control and ABX-resistant 
Achromobacter (LRCR)-colonized C57BL/6 (A) PP and (B) mLN homogenates or (C) Rag1-/- mLN 
homogenates. Data are representative of at least 2 independent experiments. (D) PP of CNV, 
ABX-treated and ABX-resistant Achromobacter (LRCR)-colonized C57BL/6 mice were analyzed 
for frequencies of IL-22+ ILC3. One-way ANOVA, *p < 0.01. (E) LRCR 16S rDNA was measured 
by PCR in sorted CD11c+ cells from ABX-treated control or LRCR-colonized Rag1-/- mLN. Data 
are representative of 2 independent experiments with 3 mice per group. Statistics in panel D were 
performed using one-way ANOVA with uncorrected Fisher’s LSD test. **, p < 0.01. 
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Figure 17. Lymphoid tissue resident-commensal bacteria promote tissue-
specific innate immune cell responses in antibiotic-treated mice.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. (A) Expression of Il1b, Il10 and Il23a was measured in sorted CD11c+ cells from ABX-
treated control or LRCR-colonized Rag1-/- mLN. Data pooled from 2 independent experiments for 
a total of 6 mice per group. (B) mLNs and (C) small intestines of CNV, ABX-treated and LRCR-
colonized were analyzed for expression of Il17a and ll22. Data pooled from 2 independent 
experiments for a total of 6-8 mice per group. One-way ANOVA, mLN Il17a – ****p < 0.0001; 
mLN Il22 – **p < 0.01; SI Il17a – ***p < 0.001; SI Il22 – **p < 0.01. Statistics in panel A were 
performed using unpaired, two-tailed, student‘s t-test. Statistics in panels B and C were 
performed using one-way ANOVA and uncorrected Fisher’s LSD test. **, p < 0.01; ***, p < 0.001; 
****, p < 0.0001. 
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Table 1. List of publically available reference genomes used in this thesis. 
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Chapter 3 
Lymphoid tissue-resident commensal bacteria-induced immune pathways 
are required for bacterial colonization and host tissue protection 
 
3.1 Abstract 
Trillions of commensal bacteria colonize the gastrointestinal tract of mammals. 
Although most commensal bacteria are found restricted to the luminal or 
epithelial surface of the intestine, some commensals, referred to as lymphoid 
tissue-resident commensal bacteria (LRC), can colonize the interior of intestinal-
associated lymphoid tissues. Chapter 2 demonstrated that LRCs elicit members 
of the IL-10 cytokine family, including DC-derived IL-10 and ILC3-derived IL-22, 
within intestinal-associated lymphoid tissues but not the small intestine lamina 
propria. This Chapter will explore the functional consequences of these LRC-
induced immune pathways. IL-22 production enhances LRC colonization by 
restricting the colonization of other commensal microbes. Furthermore, LRC-
induced IL-10 and provides host protection from lethal intestinal damage by 
limiting intestinal tissue injury and systemic inflammation. Collectively, these data 
reveal a novel host-commensal bacteria dialogue whereby selective subsets of 
commensal bacteria interact with DCs to induce tissue-specific responses that 
are mutually beneficial for both the host and microbe.  
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3.2 Introduction 
Commensal microorganisms, such as bacteria, fungi and viruses that colonize 
our gastrointestinal tract are essential for the maintenance of host health. 
Animals that lack commensal microbes or are depleted of commensals through 
the use of oral antibiotics are often highly susceptible to mouse models of 
infectious, inflammatory and metabolic diseases. Germ-free animals are unable 
to restrict colonization and infection by the bacterial pathogens Citrobacter 
rodentium, Listeria monocytogenes, Salmonella serovar Typhimurium (Inagaki et 
al., 1996; Kamada et al., 2012; Stecher et al., 2005). The mechanisms for 
enhanced susceptibility to bacterial colonization is largely dependent on lack of 
competition from the endogenous commensal microbiota, In the presence of a 
complex microbiota, which often utilize the same nutrients as pathogens, 
pathogenic bacteria are rapidly outcompeted. Collectively, the endogenous 
microbiota protects the host from invasive microbes by providing colonization 
resistance. 
The endogenous microbiota stimulates the development of intestinal and 
systemic immune responses against invading pathogens. For example, germ-
free mice colonized with the epithelial-associated commensal SFB generate 
Th17 cell responses that are protective against colonization by Citrobacter 
rodentium (Ivanov et al., 2009). On the other hand, the microbiota has also been 
shown to prime regulatory T cell responses, which are responsible for limiting 
pro-inflammatory and pathologic immune cell responses such as Th1 and Th17 
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cells. For example, the luminal commensals Bacteroides fragilis and Clostridium 
spp. promote Treg responses that are protective in multiple mouse models of 
intestinal inflammation (Atarashi et al., 2011; Round and Mazmanian, 2010). On 
the other hand, generation of pro-inflammatory immune responses by 
commensal bacteria may be detrimental to the host. Indeed, SFB-colonized 
animals, which have elevated intestinal and systemic Th17 responses, are more 
susceptible to experimental autoimmune encephalitis and autoimmune arthritis 
(Lee et al., 2011; Wu et al., 2010). 
In contrast to the hypothesis that commensal bacteria drive tissue 
inflammation in colitis, germ-free mice, antibiotic-treated mice and mice lacking 
the bacterial recognition adaptor protein MYD88 are all highly susceptible to 
DSS-induced colitis (Ayres et al., 2012; Kitajima et al., 2001; Rakoff-Nahoum et 
al., 2004). These data support the hypothesis that recognition of the endogenous 
microbiota and microbiota-dependent host physiological changes are protective 
in the context of intestinal inflammation. These data also suggest that a defined 
consortium of commensal bacteria offers intestinal tissue protection. Indeed, 
colonization of germ-free mice with Bacteroides fragilis or Clostridium spp. as 
previously discussed is host protective during colitis (Atarashi et al., 2011; Round 
and Mazmanian, 2010). However, other commensals, such as Prevotella and 
Helicobacter, do not provide host protection and instead drive disease 
development (Palm et al., 2014). Despite these findings, the functional 
significance of bacteria colonization by LRCs has not been explored. 
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  Host biological pathways are critical for the maintenance of healthy 
interactions with commensal bacteria through modulation of intestinal barrier 
functions including production of anti-microbial peptides, mucus and IgA. One 
pathway that is critical for maintenance of intestinal barrier function is the 
production of IL-22. IL-22 is an IL-10 cytokine family member that stimulates the 
production of antimicrobial peptides and delivers pro-proliferative signals to cells 
necessary for host tissue homeostasis (Rutz et al., 2013; Sonnenberg et al., 
2011). In support of a role for IL-22 in regulating the microbiota, Il22-/- mice have 
a dysbiotic microbiota that is transmissible and colitogenic (Zenewicz et al., 
2013). Mice that lack molecular factors upstream of the IL-22 pathway such as 
Rorc-/- and Ahr-/- mice also demonstrate expansion of the epithelial-associated 
commensal SFB (Qiu et al., 2013; Upadhyay et al., 2012). Furthermore, IL-22 
has been shown to suppress the luminal commensal E. coli in the context of 
Salmonella infection. Collectively, it can be concluded that IL-22 is a critical 
cytokine that restricts luminal and epithelial-associated commensal bacteria 
colonization. Despite this, the role of IL-22 induced by LRCs is not known and will 
be explored in this Chapter. 
Chapter 2 demonstrated that LRCs can colonize the interior of DCs in 
vitro and intestinal-associated lymphoid tissues in vivo to elicit tissue-specific 
Th17 and IL-22 responses. This Chapter will demonstrate that, in contrast to 
previously identified roles for IL-22 in limiting intestinal colonization by 
commensal bacteria (Qiu et al., 2013; Rutz et al., 2013; Shih et al., 2014; 
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Upadhyay et al., 2012), IL-22 enhances LRC colonization of intestinal-associated 
lymphoid tissues. On the other hand, LRC-induced IL-10 limits pro-inflammatory 
responses in the steady state and could protect mice in a model of intestinal 
damage. These data collectively suggest that LRCs engage in a mutualistic 
dialogue with mammalian hosts by eliciting members of the IL-10 cytokine family. 
 
3.3 Methods  
 
3.3.1 Mice 
C57BL/6 and Rag1-/- mice were purchased from Jackson Laboratories and used 
at 6-12 weeks of age. Conventional mice used as controls in gnotobiotic mice 
experiments were purchased from Jackson Laboratories and co-housed with 
mice bred in our conventional animal facility for at least 7 days before use. 
C57BL/6 and Rag1-/- mice used as controls for knockout mice were either bred in 
the same animal facility as the knockout mice, purchased from Jackson 
Laboratories and co-housed with mice bred in our SPF animal facility for at least 
7 days or littermates as indicated to normalize for microbiota differences. All 
conventional mice were maintained in specific pathogen-free facilities at the 
University of Pennsylvania or Weill Cornell Medical College. Germ-free and 
gnotobiotic C57BL/6 and Rag1-/- mice were maintained within sterile vinyl 
isolators at the University of Pennsylvania or Weill Cornell Medical College 
Gnotobiotic Mouse Facility and monitored for germ-free or gnotobiotic status by 
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weekly aerobic and anaerobic culturing. Germ-free and gnotobiotic Il10+/+ and 
Il10-/- mice were maintained at the National Gnotobiotic Rodent Resource Center 
(University of North Carolina, Chapel Hill). Additional microbiology testing was 
performed on feces from mice under experimentation and at the endpoint of the 
experiment to confirm germ free or monocolonization status. DSS experiments 
using gnotobiotic mice were performed in a biosafety cabinet, and the gnotobiotic 
status of mice was confirmed by microbiology testing. Germ-free C57BL/6 mice 
were monocolonized with the mouse LRC isolate Bordetella spp., or SFB by oral 
gavage or cohousing with soiled bedding from previously monocolonized mice for 
at least 10 days. To establish LRC colonization in ABX-treated mice, 
conventional mice were treated in the drinking water with a limited ABX cocktail 
of ampicillin (1 mg/ml, Sigma) and gentamicin (1 mg/ml, Gemini Bio-Products) for 
C57BL/6, Il22-/- and Il17a-/- mice or ampicillin (1 mg/ml), gentamicin (1 mg/ml) and 
neomycin (0.25 mg/ml, Sigma) for Rag1-/- and Rag1-/- Il22-/- for 3 days and then 
orally gavaged with the clinical LRC isolate (LRCR), Achromobacter. Neomycin 
(0.25 mg/ml), metronidazole (0.5 mg/ml, Sigma) and vancomycin (0.25 mg/ml, 
Chem-Impex International) were added to the limited ABX cocktail as indicated. 
Antibiotic cocktails were supplemented with 1 packet of artificial sweetener 
(Sweet’N Low) per 250 ml. For cytokine treatments in vivo, rmIL-22 or PBS 
control (kindly provided by Pfizer) was injected i.p. at 25 µg/mouse every 2 days 
for 1 week and control- or IL-22-Fc (kindly provided by Pfizer) was injected i.p. at 
50 µg/mouse every 3 days for 1 week. First injections were administered 1 day 
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prior to LRCR colonization. For quantification of Th17 cells in the absence of IL-
10, either LRC-monocolonized Il10-/- mice, or LRC-monocolonized GF C57BL/6 
mice treated with 500 µg/mouse anti-IL-10R (clone 1B1.3A, Bio X Cell) i.p. every 
3 days for 1 week, was used. All mice were used at least 10 days post LRCR 
colonization. All animals used are on a C57BL/6 background with the exception 
of Il10-/- and Il10+/+ germ free mice, which are on a 129S6/SvEv background. All 
experiments were performed according to the guidelines of the University of 
Pennsylvania or Weill Cornell Medical College Institutional Animal Care and Use 
Committee. 
 
3.3.2 Microbiology 
The LRC strain, Bordetella spp., used to colonize BMDCs or monocolonize germ-
free mice was originally isolated from the spleen of an anti-CD90.2 mAb treated 
conventional Rag1-/- mice using a previously defined protocol (Sonnenberg et al., 
2012). The ABX-resistant (ampicillin, gentamicin, neomycin) LRC (LRCR), 
Achromobacter used to colonize antibiotic-treated mice were human clinical 
isolates kindly provided by Kaede V. Sullivan (Children’s Hospital of 
Philadelphia). Bacterial identities were determined by genomic sequencing 
(Wellcome Trust Sanger Institute) and confirmed by genus-specific 16S rDNA 
primers. All bacterial strains used to colonize GF mice and for in vitro DC assays 
were grown in LB broth and incubated at 250 RPM, 37°C for 16-20 hours. For 
enumeration of tissue and fecal CFUs, the spleen, liver, feces, mesenteric lymph 
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nodes (mLN) and Peyer’s patches (PP) were isolated, homogenized in sterile 
PBS and plated on Brain Heart Infusion agar supplemented with 5% defibrinated 
horse blood. When culturing LRCR from tissues and feces, BHI blood agar plates 
were supplemented with 25 µg/ml ampicillin.  
 
3.3.3 Quantitative real-time PCR 
RNA was isolated using TRIzol reagent (Life Technologies) according to the 
manufacturer’s instructions. cDNA was generated using Superscript reverse 
transcriptase II (Invitrogen). Quantitative real-time PCR was performed using 
SYBR green chemistry (Invitrogen) and QuantiTect Primer Assays (Qiagen) on 
the ABI 7500 real-time PCR system (Applied Biosystems). Samples were 
normalized to β-actin and displayed as fold change over antibiotic-treated mice.  
 
3.3.4 Flow cytometry 
Peyer’s patches were harvested and single-cell suspensions were prepared at 
necropsy. For flow cytometric analyses, cells were stained with antibodies 
against the following markers: anti-NK1.1 (clone PK136, eBioscience), anti-CD3 
(clone 145-2C11, eBioscience), anti-CD5 (clone 53-7.3, eBioscience), anti-
CD11c (clone N418, eBioscience), anti-CD4 (clone GK1.5, Abcam), anti-CD8α 
(clone 53-6.7, eBioscience), anti-B220 (clone RA3-6B2, eBioscience), anti-CD45 
(clone 30-F11, eBioscience) and anti-CD11b (clone M1/70, eBioscience). For 
intracellular staining of RORγt, cells were fixed and permeabilized with the Foxp3 
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intracellular staining buffer set (eBioscience) and stained with anti-RORγt (clone 
B2D, eBioscience). For intracellular cytokine staining, cells were stimulated ex 
vivo by incubation for 4 h with 50 ng/mL PMA, 750 ng/mL ionomycin, 10 µg/mL 
Brefeldin A (all obtained from Sigma-Aldrich) and 50 ng/mL rmIL-23 
(eBioscience) and permeabilized as indicated above and stained anti-IL22-02 
(mouse cytokine detection antibody developed by Pfizer). Dead cells were 
excluded from analysis using the Live/Dead Aqua Viability Kit (Invitrogen). Flow 
cytometry data collection was performed on the LSR II (BD Biosciences). Data 
were analyzed using FlowJo software (Tree Star Inc.).   
 
3.3.5 DSS-induced intestinal damage 
Mice were administered 2% DSS (MW 36,000-50,000, MP Biochemicals) in their 
drinking water ad libitum for the number of days indicated and then placed on 
regular drinking water. Disease severity was cumulatively scored based on rectal 
bleeding (out of 2), fecal consistency (out of 2), general appearance (out of 4), 
weight loss (out of 4) and rectal temperature (out of 4). For antibody treatments 
during DSS, mice were administered i.p. 500 µg/mouse of rat IgG, anti-IL22-01 
(mouse neutralizing antibody developed by Pfizer) or anti-IL-10R (clone 1B1.3A, 
Bio X Cell) 1 day prior to DSS treatment, then on days 2, 5 and 7. Mice were 
sacrificed on day 8. 
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3.3.6 Histology 
Tissues from the small and large intestines were fixed with 4% PFA, embedded 
in paraffin, and 5 µm sections were cut and stained with H&E. 
 
3.3.7 Statistical analyses 
Results represent mean ± SEM and statistical analyses were performed by 
unpaired student’s t-test, Mann-Whitney test, or one- or two-way ANOVA with or 
without multiple comparisons tests as indicated in figure legends. 
 
3.4 Results 
 
3.4.1 Loss of IL-22 is associated with impaired colonization by lymphoid 
tissue-resident commensal bacteria 
Multiple reports suggest that IL-17A and IL-22 limit intestinal colonization of the 
commensal bacterium SFB (Qiu et al., 2013; Rutz et al., 2013; Shih et al., 2014; 
Upadhyay et al., 2012). Therefore, we hypothesized that induction of IL-17A and 
IL-22 by LRCs would be important in limiting its own colonization in intestinal-
associated lymphoid tissues. To examine the role for IL-17A and IL-22 in LRC 
colonization, ABX-treated C57BL/6, Il17a-/- and Il22-/- mice were inoculated with 
LRCR and lymphoid tissue colonization was assessed 10 days post-inoculation. 
Based on the requirement for IL-22 in restricting Alcaligenes dissemination 
(Sonnenberg et al., 2012), we also predicted that colonization of Il22-/- mice with 
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LRCR would result in systemic dissemination of LRCR. However, systemic 
dissemination of LRCR was not observed in the absence of either IL-17A or IL-22 
(Figure 18A). Furthermore, analysis of intestinal-associated lymphoid tissues 
revealed an impaired ability of LRCR to colonize the mLN and PPs of Il22-/- but 
not C57BL/6 or Il17a-/- mice (Figure 19A and 19B). These data suggest that IL-22 
may also facilitate colonization of lymphoid tissues by commensal bacteria. 
ILC3s are major producers of IL-22 in the intestine of healthy mammals (Artis 
and Spits, 2015; Diefenbach et al., 2014; McKenzie et al., 2014; Sonnenberg and 
Artis, 2012, 2015; Sonnenberg et al., 2012). To test whether innate cell-derived 
IL-22 could impact lymphoid tissue colonization by commensal bacteria, we 
inoculated ABX-treated Rag1-/- and Rag1-/-Il22-/- mice with LRCR and measured 
lymphoid tissue colonization. Similar to the findings using lymphocyte-sufficient 
Il22-/- mice, inoculation of Rag1-/-Il22-/- mice with LRCR did not result in systemic 
dissemination of LRCR (Figure 18B), but resulted in impaired LRCR colonization 
in the mLN (Figure 19C). Collectively, these results suggest that induction of ILC-
derived IL-22 by LRCs is important to facilitate its colonization of lymphoid 
tissues.  
 
3.4.2 Impaired lymphoid tissue-resident commensal bacteria colonization in 
Il22-/- mice is dependent on a dominant and transmissible microbiota  
Expression of the IL-22 receptor is restricted to non-hematopoietic cells and IL-
22-IL-22R signaling regulates antimicrobial responses in the intestinal lumen and 
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the composition of the microbiota (Qiu et al., 2013; Shih et al., 2014; Sonnenberg 
et al., 2011; Zenewicz et al., 2013). Therefore, rather than a direct effect on DCs, 
we hypothesized that in the absence of IL-22 there may be an expansion of 
commensal bacteria that outcompete and limit LRC entry and colonization. To 
investigate this hypothesis, we measured luminal bacterial colonization in 
C57BL/6, Il22-/-, Il17a-/-, Rag1-/- and Rag1-/-Il22-/- mice that were treated with a 
limited ABX cocktail followed by LRCR inoculation. At 10 days post-inoculation, 
we detected an absence of fecal LRCR in Il22-/- and Rag1-/-Il22-/- but not in 
C57BL/6, Rag1-/- and Il17a-/- mice (Figure 20A and 20B). Il22+/+ littermates raised 
under the same conditions as Il22-/- mice also have impaired ABX-mediated fecal 
LRC colonization, and administration of additional antibiotics including neomycin, 
metronidazole and vancomycin, restored fecal LRC colonization in Il22-/- mice 
and Il22+/+ littermates (Figure 20C). Furthermore, cohousing Il22-/- mice with 
C57BL/6 mice impaired fecal and lymphoid tissue LRC colonization in C57BL/6 
mice (Figure 20D). Altogether, these data indicate that IL-22 promotes LRC 
colonization by limiting competition with other commensal microbes. 
 
3.4.3 Exogenous administration of IL-22 enhances lymphoid tissue-resident 
commensal bacteria colonization 
To further interrogate the role of IL-22 in regulating LRC colonization, we pursued 
a gain-of-function approach. Consistent with a role for IL-22 in promoting 
lymphoid tissue colonization by LRCs, exogenous administration of recombinant 
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mouse IL-22 to LRCR-colonized Rag1-/- mice significantly enhanced LRCR levels 
in the mLN (Figure 19D). These data suggest that IL-22 is sufficient to promote 
lymphoid tissue colonization by LRCs. 
 
3.4.4 IL-22 regulates lymphoid tissue-resident commensal bacteria 
colonization in the presence of a complex microbiota 
The LRCR colonization model requires the use of antibiotics that eliminate most 
commensal bacteria in the intestine. To test the requirement for IL-22 in LRC 
colonization in the presence of a complex microbiota, we measured levels of the 
endogenous LRC, Alcaligenes by fluorescence in situ hybridization (FISH) in 
conventional Il22-/- mice and littermate controls. Compared to Il22+/+ littermates, 
conventional Il22-/- mice have reduced Alcaligenes puncta in the PP and mLN 
(Figure 21A and 21B). These data demonstrate that IL-22 plays a critical role in 
enhancing the colonization of intestinal-associated lymphoid tissues by LRCs in 
the presence of a complex microbiota. 
 
3.4.5 Loss of IL-10 results in elevated lymphoid tissue-resident commensal 
bacteria-induced Th17 cell responses in gnotobiotic mice 
Although induction of Th17 cell responses were observed in the PP and mLN of 
LRC-monocolonized mice, the magnitude of these responses was lower than that 
observed in SFB-monocolonized mice (Figure 12A-D), raising the possibility that 
LRCs are less efficient at inducing Th17 cell responses or are actively limiting 
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Th17 cell responses.  Since LRCs could promote IL-10 by DCs (Figures 9A-D 
and 17A) and IL-10 has been shown to suppress IL-17 responses (Liu et al., 
2011a; McGeachy et al., 2007; Ouyang et al., 2011), we hypothesized that IL-10 
may restrain LRC-induced Th17 cell responses. Consistent with this hypothesis, 
Th17 cells were significantly increased in the mLN (Figure 22A and 22B) and PP 
(Figure 22C and 22D) of LRC-monocolonized Il10-/- mice compared to LRC-
monocolonized wild type mice. Collectively, these data demonstrate that LRCs 
selectively promote local Th17 cell responses in intestinal-associated lymphoid 
tissues, and that the magnitude of these responses is limited by co-induction of 
IL-10. 
 
3.4.6 Lymphoid tissue-resident commensal bacteria colonization provides 
host protection from DSS-induced intestinal inflammation and injury  
IL-22 is important for regulating immune homeostasis and maintenance of the 
intestinal barrier following infection or tissue damage (Ouyang et al., 2011; Rutz 
et al., 2013; Sonnenberg et al., 2011). The finding that LRCs induce IL-22 raises 
the possibility that LRCs may provide intestinal protection following tissue 
damage. To test this, we employed a model of intestinal damage where 
administration of the chemical, dextran sodium sulfate (DSS), induces significant 
damage to the colonic epithelium. Compared to CNV mice, mice lacking 
commensal bacteria or treated orally with a broad-spectrum cocktail of antibiotics 
are highly sensitive to intestinal damage induced by DSS and succumb to 
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disease (Ayres et al., 2012; Kitajima et al., 2001; Maslowski et al., 2009). To test 
the functional significance of LRC colonization following DSS treatment, we 
administered 2% DSS to CNV, ABX-treated alone and LRCR-colonized Rag1-/- 
mice for 6-7 days, then removed DSS, re-administered normal drinking water and 
monitored their survival, weight loss and parameters of inflammation. Compared 
to CNV mice, which survived throughout the duration of the experiment (21 
days), ABX-treated mice exhibited significant systemic and intestinal morbidity 
and succumbed to disease by day 10 post DSS administration (Figure 23A, 23C 
and 23D). In contrast, LRCR-colonized mice were largely protected from DSS-
induced mortality, and demonstrated significantly reduced weight loss and 
elevated red blood cell counts as compared to ABX-treated controls (Figure 23A-
D). Further, analysis of intestinal tissue damage on day 5 post DSS 
administration revealed that although CNV mice did not exhibit significant 
intestinal damage or inflammation in the colon at this low dose of DSS, the 
colons of ABX-treated mice displayed severe loss of crypt architecture and 
extensive inflammation (Figure 24). In contrast, LRCR-colonized mice had visible 
but reduced intestinal tissue damage and inflammation (Figure 24). LRCR-
conferred protection from DSS-induced mortality was also observed in 
gnotobiotic C57BL/6 (Figure 25A) and Rag1-/- (Figure 25B) mice monocolonized 
with the mouse-derived LRC, Bordetella spp., suggesting that host protection can 
occur in the absence of other commensal bacteria. Collectively, these data 
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demonstrate that colonization of lymphoid tissues by selective commensal 
bacteria is host beneficial in the context of intestinal damage and inflammation. 
 
3.4.7 Lymphoid tissue-resident commensal bacteria-induced IL-10 provides 
host protection from DSS-induced intestinal injury and systemic 
inflammation 
To investigate whether LRC-induced IL-22 is providing host protection in LRCR-
colonized mice, we administered anti-IL-22 neutralizing antibody to LRCR-
colonized Rag1-/- mice during exposure to DSS. Anti-IL-22-treated mice exhibited 
comparable weight loss to IgG-treated mice (Figure 26C), suggesting that IL-22 
is not involved in LRC-mediated host protection from DSS. As the anti-
inflammatory cytokine IL-10 was also induced upon LRC colonization both in the 
steady state and during DSS exposure (Figure 9, 17A and Figure 26A), we 
interrogated whether innate cell-derived IL-10 is providing host protection in 
LRCR-colonized mice. To test this, we administered anti-IL-10R neutralizing 
antibody to LRCR-colonized Rag1-/- mice during exposure to DSS. Blockade of 
IL-10-IL-10R interactions resulted in increased weight loss and colonic 
inflammation as compared to IgG-treated controls (Figure 26D, 27). ABX-treated 
Rag1-/- mice on DSS water display elevated levels of serum IFNγ, which was 
significantly diminished in LRCR-colonized Rag1-/- mice (Figure 26B). Conversely, 
IL-10R neutralization in LRCR-colonized mice partially restored serum IFNγ levels 
observed in ABX-treated mice (Figure 26B). Treatment of ABX-only control Rag1-
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/- animals with anti-IL-10R during DSS exposure did not result in further weight 
loss or colon pathology compared to isotype-treated animals (Figure 28A-B). 
Collectively, these data suggest that LRC colonization protects mice from acute 
intestinal injury and systemic inflammatory responses through induction of innate 
cell-derived IL-10. 
 
3.5 Discussion 
This Chapter explores the role of LRC-induced immune pathways in the steady 
state and in the context of acute intestinal injury. The data suggest that LRCs 
induce IL-10 and IL-22, members of the IL-10 cytokine family, to establish 
beneficial host-commensal interactions (Figure 29).   
Multiple reports suggest that induction of the ILC3-IL-22 pathway limits 
host colonization by pathogenic attaching and effacing bacterial pathogens such 
as Citrobacter rodentium or the commensal bacterium SFB (Qiu et al., 2013; 
Rutz et al., 2013; Shih et al., 2014; Sonnenberg et al., 2011; Upadhyay et al., 
2012). In contrast, the data in this Chapter demonstrate that IL-22 facilitates 
colonization of lymphoid tissues by LRCs. Il22-/- mice harbor intestinal microbes 
that limit LRC colonization in the lumen likely through competition for space or 
nutrients. This is consistent with IL-22-induced antimicrobial functions on gram-
positive commensal bacteria (Hooper and Macpherson, 2010; Rutz et al., 2013; 
Sonnenberg et al., 2011). This also agrees with a report demonstrating a role for 
IL-22-induced lipocalin and calprotectin in enhancing Salmonella infection by 
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suppressing commensal Enterobactericeae (Behnsen et al., 2014). Critically, 
recombinant IL-22 enhanced LRC colonization in Rag1-/- mice, and reduced 
endogenous LRC colonization was observed in CNV Il22-/- compared to littermate 
controls. Reduction of endogenous LRCs in CNV Il22-/- mice may be due to 
dysbiosis as Il22-/- mice have an altered and a transmissible microbiota 
(Zenewicz et al., 2013). These data collectively suggest that IL-22 indirectly 
promotes LRC colonization in multiple contexts by restricting colonization of 
competing intestinal microbes.  
It was previously reported that ILC3-derived IL-22 is a critical pathway that 
maintains anatomical containment of LRCs in intestinal-associated lymphoid 
tissues in healthy mice and that transient loss of this pathway results in 
dissemination of Alcaligenes to systemic lymphoid tissues (Sonnenberg et al., 
2012). In the current study, systemic dissemination of a distinct but related LRC, 
Achromobacter was not observed in the absence of IL-22. Rather, Il22-/- and 
Rag1-/- Il22-/- mice had impaired lymphoid tissue entry and colonization. 
Therefore, the findings in this Chapter highlight a multifaceted role for IL-22 in 
maintaining anatomical localization of LRCs, by both promoting lymphoid tissue 
colonization and limiting systemic dissemination.  
 LRC colonization is sufficient to protect wild type and lymphocyte-deficient 
mice from lethal intestinal damage, supporting the hypothesis that host 
recognition of commensal bacteria provides beneficial microbial stimulation to 
limit intestinal injury. It was previously demonstrated that mice lacking the pattern 
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recognition receptors TLR2, TLR4 or the downstream adaptor molecule MYD88 
are also susceptible to lethal DSS-induced intestinal damage (Rakoff-Nahoum et 
al., 2004), suggesting that direct recognition of microbial signals is critical for 
maintenance of the intestinal barrier. Despite our understanding of microbial 
recognition pathways in host protection from intestinal injury, the downstream 
signals induced are not fully understood. The data in this Chapter suggest that 
MYD88-dependent IL-10 induction by LRCs is one pathway that provides tissue 
protective functions in the context of intestinal injury and systemic inflammation. 
These data are consistent with the anti-inflammatory and tissue protective roles 
of IL-10 in the intestine (Asseman et al., 1999; Kuhn et al., 1993; Ouyang et al., 
2011) and that innate and adaptive IL-10 responses in the intestine are 
dramatically driven by the microbiota (Atarashi et al., 2011; Chiu and Ching, 
2014; Geuking et al., 2011; Liu et al., 2011b; Ueda et al., 2010). The data in this 
Chapter support a model whereby, following LRC colonization, IL-10 produced by 
DCs in intestinal-associated lymphoid tissues has local effects in limiting Th17 
cell responses in lymphoid tissues in the steady state, as well as distal effects on 
the intestinal epithelium and systemic circulation in the context of intestinal 
damage. 
 Collectively, the findings in this Chapter demonstrate a previously 
unrecognized and mutually beneficial dialogue between the host and lymphoid 
tissue-resident commensal bacteria (Figure 29). Colonization of lymphoid tissues 
by commensal bacteria modulates the host immune system in a tissue-specific 
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manner and confers protective effects in the context of intestinal damage. From 
an evolutionary perspective, there may be multiple beneficial functions for 
permitting colonization of mammalian lymphoid tissues by commensal bacteria. 
However, it is likely that a tightly regulated balance between beneficial and 
pathologic commensal colonization must be maintained in order to prevent 
pathologic inflammation.  
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Figure 18. Colonization of IL-22-deficient animals by lymphoid tissue-
resident commensal bacteria is not associated with bacterial 
dissemination. 
 
 
 
 
 
 
 
 
Figure 18. (A) Bacterial CFUs were determined in spleen homogenates of LRCR-gavaged 
C57BL/6, Il17a-/- and Il22-/- mice. (B) Bacterial CFUs were determined in spleen homogenates of 
LRCR-gavaged Rag1-/- and Rag1-/-Il22-/- mice. ND, not detectable. 
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Figure 19. Loss of IL-22 is associated with impaired colonization by 
lymphoid tissue-resident commensal bacteria. 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. (A and B) mLN and PP homogenates from LRCR-colonized C57BL6, Il17a-/- and Il22-/- 
mice were cultured to determine CFUs. Data are representative of at least 2 independent 
experiments  (C) mLN homogenates from LRCR-colonized Rag1-/- and Rag1-/- Il22-/- mice were 
cultured to determine CFUs. Data pooled from 2 independent experiments for a total of 5-6 mice 
per group. (D) mLN homogenates from control or recombinant mouse IL-22 (rIL-22)-treated Rag1-
/- mice were cultured to determine CFUs. Data representative of 2 independent experiments using 
recombinant mouse IL-22 or IL-22-Fc. Data are represented as mean ± SEM. Statistics in panels 
D were performed using unpaired, two-tailed, student’s t test. *, p < 0.05; ND, not detectable.  
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Figure 20. Impaired lymphoid tissue-resident commensal bacteria 
colonization in IL-22-deficient mice is dependent on the presence of 
competing microbiota. 
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Figure 20. (A and B) Fecal CFUs were determined in LRCR-gavaged C57BL/6, Il17a-/-, Il22-/-, 
Rag1-/- and Rag1-/-Il22-/- mice. Data representative of at least 2 independent experiments. (C) 
Fecal CFUs were determined in ampicillin and gentamicin (AG)-treated, LRCR-gavaged C57BL/6, 
Il22+/+ and Il22-/- mice. (D) Fecal CFUs were determined in AG-treated, LRCR-gavaged C57BL/6, 
Il22+/+ and Il22-/- mice following treatment with neomycin, metronidazole and vancomycin (NMV) 
for 1 week. One-way ANOVA, ****, p < 0.0001. (D) Fecal and mLN CFUs were determined in AG-
treated, LRCR-gavaged C57BL/6, C57BL/6 mice co-housed with Il22-/- (C57BL/6 CH) and Il22-/- 
mice. Data in B, C and D are representative of 2 independent experiments. Statistics in panel C 
were performed using one-way ANOVA and the Tukey’s multiple comparisons test. **, p < 0.01; 
***, p < 0.001; ****, p < 0.0001.  
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Figure 21.  IL-22 regulates lymphoid tissue-resident commensal bacteria 
colonization in the presence of a complex microbiota. 
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Figure 21. (A) Whole PP and (B) mLN were stained with Alcaligenes-specific 16S FISH probes 
ALBO (red) and BPA (green), and wheat germ agglutinin (blue). Data are representative of 2 
independent experiments with 2-5 mice per group. Number of puncta per mm3 of tissue was 
quantified. Data are represented as mean ± SEM. Statistics were performed using unpaired, two-
tailed, student’s t test *, p < 0.05. 
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Figure 22. Loss of IL-10 results in elevated lymphoid tissue-resident 
commensal bacteria-induced Th17 cell response in gnotobiotic mice. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Frequencies of Th17 cells (gated as RORγt+FOXP3- of Lineage+CD4+) in the (A and 
B) mLN or (C and D) Peyer’s patch of LRC-monocolonized Il10+/+ or Il10-/- mice. Data 
representative of 2 independent experiments with 2-5 mice per group using Il10-/- monocolonized 
mice or C57BL/6 monocolonized mice with anti-IL-10R treatment. One-way ANOVA, mLN, ****p < 
0.0001; PP, **p < 0.01. Cells in all flow cytometry plots are gated as live, Lineage+ and CD4+. 
Lineage cocktail consists of CD3, CD5, CD8α and NK1.1. Data are represented as mean ± SEM. 
Statistics shown in panels B and D were performed using one-way ANOVA with unpaired, two-
tailed, student’s t test and no correction for multiple comparisons. *, p < 0.05; **, p < 0.01. 
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Figure 23. Lymphoid tissue-resident commensal bacteria colonization 
provides host protection from DSS-induced mortality and weight loss. 
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Figure 23. CNV, ABX-treated and ABX-resistant Achromobacter (LRCR)-colonized-colonized 
Rag1-/- mice were administered 2% DSS in their drinking water for 6 to 7 days and then placed on 
regular drinking water. Mice were monitored for survival (A) and weight loss (B) for up to 21 days. 
Data in panel A are pooled from 2 independent experiments for a total of 8-9 mice per group. (C) 
Disease score for CNV, ABX and LRCR-colonized Rag1-/- mice treated with 2% DSS in drinking 
water for 6 days. (D) Red blood cell (RBC) counts for ABX and LRCR-colonized Rag1-/- mice 
treated with 2% DSS in drinking water for 8 days. Data pooled from 2 independent experiments 
for a total of 4-7 mice per group. Data are represented as mean ± SEM. Statistics in panels B, C 
and D were performed using unpaired, two-tailed, student’s t test with no correction for multiple 
comparisons. * p < 0.05; ***, p < 0.0001.  
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Figure 24. Lymphoid tissue-resident commensal bacteria colonization 
provides host protection from DSS-induced intestinal injury. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. CNV, ABX-treated and ABX-resistant Achromobacter (LRCR)-colonized-colonized 
Rag1-/- mice were administered 2% DSS in their drinking water for 6 to 7 days and then placed on 
regular drinking water. Mice were monitored for survival. Mice were sacrificed on day 6 and 
analyzed for colon tissue pathology and inflammatory infiltrate by H&E. Data are representative of 
2 independent experiments. Scale bar – 100 µm. 
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Figure 25. Lymphoid tissue-resident commensal bacteria provide host 
protection from DSS-induced mortality in gnotobiotic mice. 
 
 
 
Figure 25. (A) CNV, GF and Bordetella-monocolonized C57BL/6 mice were administered 2% 
DSS in the drinking water for 5 days and then placed on regular drinking water. CNV, n = 3; GF, n 
= 7; Bordetella-monocolonized, n = 9. (B) GF and Bordetella-monocolonized Rag1-/- mice were 
administered 2% DSS in the drinking water for 7-9 days and then placed on regular drinking 
water for the duration of the experiment. GF, n = 6; Bordetella-monocolonized, n = 6. Data in 
panels A and B are pooled from 2 independent experiments.  
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Figure 26. Lymphoid tissue-resident commensal bacteria-induced IL-10 
provides host protection from DSS-induced weight loss and systemic 
inflammation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. (A) Analysis of Il10 expression in the colon of 2% DSS-treated CNV, ABX-treated or 
LRCR-colonized Rag1-/- mice at day 6 post-DSS treatment. Data in A are pooled from 2 
independent experiments with a total of 5-7 mice per group.  (B) Serum IFNγ on day 8 post-DSS 
treatment. Data in panel B are pooled from 3 independent experiments for a total of 8-12 mice per 
group. One-way ANOVA - **p < 0.01. (C and D) ABX and LRCR-colonized Rag1-/- mice given rat 
IgG, anti-IL-22 or anti-IL-10R were treated with 2% DSS in the drinking water for 8 days and 
monitored for weight loss. Data in C are representative of 2 independent experiments. Data in D 
represent pooled data from 3 independent experiments. Data are represented as mean ± SEM. 
Statistics were performed using one-way ANOVA with uncorrected Fisher’s LSD test (B, D) or 
Mann-Whitney test with no correction for multiple comparisons (A). *, p < 0.05; **, p < 0.01; ***, p 
< 0.001. 
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Figure 27. Lymphoid tissue-resident commensal bacteria-induced IL-10 
provides host protection from DSS-induced intestinal injury. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. ABX, LRCR-colonized Rag1-/- mice given rat IgG or anti-IL-10R were treated with 2% 
DSS in the drinking water for 8 days and colon pathology was assessed on day 8. Scale bar – 
100 µm. Data are representative of 2 independent experiments.  
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Figure 28. Blockade of IL-10-IL-10R interactions in antibiotic-treated mice is 
not associated with enhanced intestinal tissue damage induced by DSS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. (A) Weight loss and (B) colon pathology of ABX-treated, rat IgG or anti-IL-10R-
injected Rag1-/- mice given 2% DSS for 9 days. Scale bar – 100 µm. Data are representative of 2 
independent experiments.  
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Figure 29. Lymphoid tissue-resident commensal bacteria promote 
members of IL-10 cytokine family to establish mutualism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Lymphoid tissue-resident commensal bacteria (LRC) colonize DCs in host intestinal-
associated lymphoid tissues to elicit pro- and anti-inflammatory cytokines. Colonization of 
lymphoid tissues by LRCs is also associated with the induction of tissue-specific Th17 cell and 
ILC3 responses. IL-22 enhances LRC colonization in lymphoid tissues by limiting colonization of 
other commensal bacteria. LRC-induced IL-10 limits intestinal tissue damage and suppresses 
systemic inflammation. 
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Chapter 4 
The iron-regulatory hormone hepcidin regulates host-microbe interactions 
and immune cell homeostasis 
 
4.1 Abstract 
Chronic inflammatory diseases are often associated with altered iron 
homeostasis. For example, patients with inflammatory bowel disease frequently 
exhibit anemia that is dependent on increased expression of the iron-regulatory 
hormone hepcidin. Hepcidin is expressed and secreted by hepatocytes and acts 
to limits iron absorption in the intestine and iron release from intracellular stores. 
Despite our understanding of hepcidin-mediated iron regulation, its role in 
immune cell function and host-commensal bacteria relationships is not well 
understood. This Chapter demonstrates that, in addition to hepatocytes, bone 
marrow-derived dendritic cells (BMDC) can express hepcidin and upregulate its 
expression following exposure to LRCs. Furthermore, dendritic cell (DC)-intrinsic 
hepcidin is required for intracellular colonization by LRCs. Examination of 
hepcidin-deficient mice also revealed elevated levels of the pro-inflammatory 
cytokines Il1b and Il6 and increased frequencies of IL-17A- and IFNγ-producing 
CD4 T cells in intestinal-associated lymphoid tissues. Consistent with a role for 
Th17 and Th1 cells in the pathogenesis of intestinal inflammation, hepcidin-
deficient mice exhibit delayed recovery from acute intestinal injury. Altogether, 
these results highlight a previously unrecognized role for hepcidin in immune 
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homeostasis and host-commensal bacteria interactions at the steady state and 
during intestinal inflammation. 
 
4.2 Introduction 
Iron is an essential nutrient for all living organisms. The uptake, transport and 
storage of iron are tightly regulated biological processes that are coordinated by 
multiple molecular components. In mammals, one critical pathway involves the 
iron-regulatory hormone hepcidin. Hepcidin, a 25-amino acid peptide that is 
secreted primarily by liver hepatocytes, binds to and results in the degradation of 
the membrane-bound iron exporter ferroportin (Cassat and Skaar, 2013; Ganz 
and Nemeth, 2015; Zhao et al., 2013). As a result, hepcidin-ferroportin 
interactions control iron levels in the plasma and intracellular stores. Hepcidin 
expression is regulated cell-extrinsically by three major factors: plasma iron 
levels, inflammatory cytokines and erythropoiesis. Studies have demonstrated 
that upregulation of hepcidin during inflammation functions as a host protective 
pathway to prevent extracellular pathogen infection by limiting their access to 
iron. For example, hepcidin-deficient mice are highly susceptible to infection by 
the pathogens Vibrio vulnificus and Yersinia enterocolitica (Arezes et al., 2015; 
Quenee et al., 2012). Conversely, hepcidin deficiency may be protective during 
infection by obligate intracellular pathogens due to low intracellular iron, an 
essential nutrient for these microbes. Mice with a mutation in HFE, an adaptor for 
iron sensing, have reduced intracellular iron due to impaired expression of 
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hepcidin (Wang et al., 2008). Hfe-/- mice displayed prolonged survival and 
enhanced control of bacterial replication during septicemia from the intracellular 
pathogen Salmonella Typhimurium (Nairz et al., 2009). Furthermore, Hfe-/- 
macrophages had reduced bacterial load compared to wild-type macrophages 
when infected with Salmonella Typhimurium. Altogether, these results 
demonstrate that hepcidin-regulated iron homeostasis is a critical pathway for the 
maintenance of antibacterial host responses.  
Although the interaction between hepcidin and ferroportin has been well 
characterized, the role of hepcidin in regulating host-commensal relationships 
and immune cell function is not well understood. This Chapter will demonstrate 
that in addition to hepatocytes, DCs are a cellular source of hepcidin in vitro, and 
in the absence of hepcidin, LRC colonization in DCs is impaired. In the absence 
of hepcidin in vivo, mice exhibit elevated pro-inflammatory cytokine production 
and IL-17A+ and IFNγ+ CD4 T cell responses in the gut draining lymph node. 
Consistent with a role for Th1 and Th17 cells in the pathogenesis of intestinal 
inflammation, loss of hepcidin is associated with exacerbated tissue damage and 
delayed recovery from acute intestinal injury. These results define iron 
homeostasis as a critical pathway regulating immune cell homeostasis and host-
commensal bacteria relationships in the intestine and associated lymphoid 
tissues. 
 
 
	   119 
4.3 Methods 
 
4.3.1 Mice 
C57BL/6 mice were purchased from Jackson Laboratories. Hamp1-/- mice on a 
C57BL/6 background were generated by Sophie Vaulont (Lesbordes-Brion et al., 
2006) and kindly provided by Stefano Rivella (Children’s Hospital of 
Philadelphia). Genome scanning for 153 SNPs confirmed that Hamp1-/- mice are 
98.67% C57BL/6 (Jackson Laboratories). Age and gender matched C57BL/6 
mice used as controls were purchased from Jackson Laboratories and cohoused 
with Hamp1-/- mice for at least 3 weeks before use. Analysis of fecal 16S rDNA 
qPCR for groups of common mouse commensal bacteria showed that microbiota 
of Hamp1-/- mice did not differ significantly from wild-type mice at the phylum and 
genus levels following cohousing. All experiments were performed according to 
the guidelines of the Weill Cornell Medical College Institutional Animal Care and 
Use Committee. 
 
4.3.2 Bone marrow-derived dendritic cells 
Bone marrow-derived DCs were generated by culturing bone marrow cells from 
C57BL/6 and Hamp1-/- mice in the presence of 20 ng/mL GM-CSF for 8-10 days. 
Culture media was replaced with fresh media every 3 days. Frequencies of 
CD11c+ cells were ≥ 95%. For intracellular bacterial survival assays, BMDCs 
were seeded on 6-well plates at 5 x 106 cells/well in antibiotic-free media and co-
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cultured with bacteria at an MOI of 50 for 2 hours, harvested and washed 3 times 
with sterile PBS. BMDCs were then plated in media containing gentamicin (100 
µg/mL) at 200,000 cells/well on 48-well plates and lysed with sterile water every 
48 hours to enumerate CFUs. For gene expression analyses, BMDCs were co-
cultured with bacteria at an MOI of 50 for 2 hours and then gentamicin-treated to 
kill extracellular bacteria. Cell lysates were prepared 24 hours later. All cell 
incubations were performed at 37°C and 5% CO2. 
 
4.3.3 Gene expression profiling and quantitative real-time PCR  
RNA was isolated from BMDCs using the RNeasy Mini Kit (Qiagen) according to 
the manufacturer’s instructions. cDNA was generated using Superscript reverse 
transcriptase II (Invitrogen). Quantitative real-time PCR was performed using 
SYBR green chemistry (Invitrogen) and QuantiTect Primer Assays (Qiagen) on 
the ABI 7500 real-time PCR system (Applied Biosystems). Samples were 
normalized to β-actin and displayed as fold change over PBS-treated BMDCs. 
For microarray analysis, BMDCs colonized with the LRC, Bordetella spp., for 4 
days were lysed directly in TRIzol. RNA was isolated, amplified, reverse-
transcribed to cDNA and hybridized to an Affymetrix GeneChip (Mouse Gene 
1.0ST) by the University of Pennsylvania Molecular Profiling Facility. Relative 
expression data was normalized by Z score transformation. 
 
 
	   121 
4.3.4 DSS-induced intestinal damage 
Mice were administered 2.5% DSS (MW 36,000-50,000, MP Biochemicals) in 
their drinking water ad libitum for 7 days and then placed on regular drinking 
water. Mice were monitored for weight loss throughout the course of the 
experiment. 
 
4.3.5 Flow cytometry 
Mesenteric lymph nodes were excised and single-cell suspensions were 
prepared at necropsy. For large intestine lamina propria preparations, intestines 
were excised, attached fat and PPs were removed and tissues were cut open 
longitudinally. Luminal contents were removed by shaking in cold PBS. Epithelial 
cells and intra-epithelial lymphocytes were removed by shaking tissue in stripping 
buffer (100 I.U./ml pencillin, 100 µg/ml streptomycin, 1 mM EDTA, 1 mM DTT 
and 5% FCS) at 37°C for 30 minutes. The lamina propria layer was isolated by 
digesting the remaining tissue in 1 mg/mL collagenase/dispase (Roche) and 20 
µg/mL DNase I (Sigma-Aldrich) for 30 minutes at 37°C. For flow cytometric 
analyses, cells were stained with antibodies against the following markers: anti-
CD3 (clone 145-2C11, eBioscience), anti-CD5 (clone 53-7.3, eBioscience), anti-
CD4 (clone GK1.5, Abcam), and anti-CD45 (clone 30-F11, eBioscience). For 
intracellular staining of RORγt, cells were fixed and permeabilized with the Foxp3 
intracellular staining buffer set (eBioscience) and stained with anti-RORγt (clone 
B2D, eBioscience). For intracellular cytokine staining, cells were stimulated ex 
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vivo by incubation for 4 h with 50 ng/mL PMA, 750 ng/mL ionomycin, 10 µg/mL 
Brefeldin A (all obtained from Sigma-Aldrich) and permeabilized as indicated 
above and stained with anti-IL-17A (clone eBioTC11-18H10.1, eBioscience), 
anti-IFN-γ (clone XMG1.2, eBioscience) and anti-TNFα (clone MP6-XT22, 
eBioscience). Dead cells were excluded from analysis using the Live/Dead Aqua 
Viability Kit (Invitrogen). Flow cytometry data collection was performed on the 
LSR Fortessa (BD Biosciences). Data were analyzed using FlowJo software 
(Tree Star Inc.).   
 
4.3.6 Histology 
Tissues from the large intestines were fixed with 4% PFA, embedded in paraffin, 
and 5 µm sections were cut and stained with H&E. 
 
4.3.7 Statistical analyses 
Results represent mean ± SEM and statistical analyses were performed by 
unpaired student’s t-test, one- or two-way ANOVA with or without multiple 
comparisons tests as indicated in figure legends. 
 
4.3.8 Data accessibility 
Array data have been deposited in GEO under accession number GSE76731. 
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4.4 Results 
 
4.4.1 Bone marrow-derived dendritic cells upregulate hepcidin expression 
following exposure to lymphoid tissue-resident commensal bacteria 
In Chapter 2, microarray-based gene expression profiling was performed on DCs 
colonized with the mouse-derived LRC, Bordetella spp. compared to DCs treated 
with PBS. Analysis of these results indicated that colonization of Bordetella 
significantly altered the expression of genes associated with iron storage, 
transport and uptake, which include those that encode for transferrin, transferrin 
receptor, ferroportin, lipocalin 2 and hemoglobin beta-chain (Figure 30). 
Hepcidin, encoded by Hamp1, was also highly upregulated in Bordetella-
colonized DCs and is considered to be a master regulator of systemic iron 
homeostasis. Upregulation of Hamp1 in bacterial-colonized DCs was confirmed 
by real time PCR (Figure 31). To investigate whether bacterial-derived products 
are sufficient to induce hepcidin, BMDCs were treated with various TLR ligands 
for 24 hours and hepcidin expression was measured. Consistent with exposure 
to whole bacteria, BMDCs exposed to LPS, Pam3CSK4 and CpG DNA 
upregulated Hamp1 (Figure 31). Collectively, these data suggest that in addition 
to hepatocytes, BMDCs are a cellular source of hepcidin and BMDCs can 
upregulate hepcidin in response to bacteria in vitro.  
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4.4.2 Loss of hepcidin in bone marrow-derived dendritic cells results in 
impaired intracellular bacterial survival by lymphoid tissue-resident 
commensal bacteria 
Data from Chapter 2 demonstrated that LRCs could persist and survive in bone 
marrow-derived and primary DCs (Figure 7B-D). Given the role of hepcidin in 
modulating intracellular iron, an essential nutrient for most microbes, and that 
hepcidin is upregulated in BMDCs following LRC colonization, one hypothesis is 
that Hamp1-/- BMDCs will not support intracellular colonization by LRCs. To test 
this, wild-type or Hamp1-/- BMDCs were exposed to the mouse LRC, Bordetella 
spp. or the non-LRC, E. coli, and intracellular survival was assessed over time. 
Although Bordetella spp. initially colonized Hamp1-/- BMDCs, the amount of live 
Bordetella spp. that survived in Hamp1-/- BMDCs was significantly reduced at 48 
and 96 hours post-colonization (Figure 32). In contrast, E. coli survival was not 
affected by hepcidin deficiency. Collectively, these results suggest that DC-
intrinsic hepcidin is important for efficient intracellular colonization by LRCs. 
 
4.4.3 Loss of hepcidin is associated with altered immune cell homeostasis 
in vivo 
Hepcidin is induced in vivo by inflammatory cytokines, such as IL-6, generated 
during host exposure to microorganisms including fungi, bacteria and viruses 
(Nemeth et al., 2004). In Hamp1-/- mice, levels of serum and liver iron are 
significantly increased whereas splenic iron levels are significantly decreased 
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(Lesbordes-Brion et al., 2006). Despite these data, the role of hepcidin in 
immune cell homeostasis in vivo has not been well characterized. To test this, 
Hamp1-/- mice were analyzed for expression of innate immune cytokines. Gene 
expression analyses of innate cell-derived cytokines in the mLN of Hamp1-/- mice 
indicated elevated expression of the pro-inflammatory cytokines Il1b and Il6 but 
not Il10 and Il12b (Figure 33). Collectively, these data suggest that hepcidin or 
hepcidin-regulated iron homeostasis controls innate immune function in vivo.  
IL-1β and IL-6 are innate immune cytokines that promote CD4 T cell 
responses, namely Th17 cells. We hypothesize enhanced Il1b and Il6 expression 
in Hamp1-/- mice may lead to elevated Th17 cell responses. To test this, we 
analyzed the frequency of IL-17A+ CD4 T cells in wild-type and Hamp1-/- mice. 
CD4 T cells from the spleen, mLN and colon of Hamp1-/- mice had elevated 
expression of IL-17A (Figure 34A). Notably, hepcidin-deficiency does not result in 
selective induction of Th17 cells as IFNγ-producing Th1 cells were also induced 
(Figure 34A). Consistent with elevated Th17 cells, frequencies of Foxp3+ or 
Foxp3- RORγt+ CD4 T cells were increased in Hamp1-/- mice (Figure 34B). 
Altogether, these results demonstrate that loss of hepcidin in vivo is associated 
with elevated proinflammatory CD4 T cell responses.  
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4.4.4 Altered immune cell homeostasis in hepcidin-deficient mice is not due 
to intestinal dysbiosis 
Since commensal bacteria regulate intestinal and systemic Th17 responses, we 
tested whether elevated Th17 responses in Hamp1-/- are due to changes in the 
composition of the microbiota. We compared Hamp1-/- mice to wild-type mice 
cohoused with their knockout counterparts for at least 3 weeks. Analysis of fecal 
16S rDNA from representative groups of the normal mouse microbiota indicated 
that levels of Bacteroides, Firmicutes, SFB, Lactobacillus and 
Enterobacteriaceae in the intestine of Hamp1-/- mice did not significantly differ 
from co-housed wild-type mice (Figure 35). Altogether, these results suggest that 
dysregulated innate and adaptive immune cell homeostasis in Hamp1-/- is not 
due to dysbiosis but more likely due to interactions between hepcidin itself or 
hepcidin-mediated iron homeostasis and the host immune system. 
 
4.4.5 Loss of hepcidin is associated with delayed intestinal repair from 
DSS-induced intestinal injury 
Th1 and Th17 cells can promote tissue pathology and inflammation in mouse 
models of intestinal injury (Neurath, 2014; Weaver et al., 2013). We hypothesize 
that elevated proinflammatory CD4 T cells in Hamp1-/- mice may predispose 
them disease during intestinal inflammation. To test this, we administered DSS to 
wild-type and Hamp1-/- mice. Although weight loss between wild-type and 
Hamp1-/- mice were not significantly different during DSS treatment, Hamp1-/- 
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mice demonstrated delayed recovery from DSS-induced weight loss (Figure 
36A). Consistent with this, analysis of tissue pathology revealed that there were 
increased inflammatory infiltrates and loss of crypt architecture in the colons of 
Hamp1-/- mice compared to wild-type colons during recovery from DSS (Figure 
36B). Analysis of immune cell function during recovery from DSS indicated that 
frequencies of IL-17A+, IFNγ+ and TNFα+ CD4 T cells were significantly increased 
in the colons and mLN of Hamp1-/- mice (Figure 37 and 38A). Furthermore, 
Hamp1-/- mice had increased frequencies of neutrophils in the intestine (Figure 
38B). Collectively, these results suggest that elevated pro-inflammatory immune 
responses in Hamp1-/- are associated with exacerbated tissue damage and 
delayed recovery from acute intestinal injury. 
 
4.5 Discussion 
This Chapter demonstrates that in addition to hepatocytes, BMDCs are a source 
of hepcidin in vitro. This finding parallels a previous report, which provided 
evidence that macrophages and neutrophils upregulate the expression of 
hepcidin mRNA and protein in response to Mycobacteria tuberculosis, 
Pseudomona aeruginosa and Streptococcus (Peyssonnaux et al., 2006; Sow et 
al., 2007). Despite the fact that hepcidin gene expression is upregulated 
however, further studies are necessary to determine whether hepcidin protein 
production and secretion is also increased in bacteria-stimulated BMDCs. In vivo, 
hepatocytes appear to be the primary source of hepcidin at the steady state. To 
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address whether hepcidin is expressed by immune cells in vivo, hepcidin 
expression should be measured in lymphoid organs and compared to the liver 
during steady state and inflammation. Since DCs, macrophages and neutrophils 
are some of the first cellular responders to sites of inflammation (Peyssonnaux et 
al., 2006; Sow et al., 2007), it is interesting to speculate that these cells may 
provide an early, localized source of hepcidin, which acts to limit iron available to 
invading pathogens during infection or colonization with commensal bacteria. In 
contrast, hepatocytes respond rapidly to systemic inflammation by upregulating 
hepcidin and may act to control systemic sequestration of iron from invasive 
pathogens. One hypothesis may be that there is a division of labor between 
immune cells and hepatocytes for promoting localized versus systemic iron 
sequestration. One approach to determine whether there are differential 
functions for hepcidin derived from immune cells relative to hepatocytes is to 
generate bone marrow chimeric animals that lack hepcidin either in the 
hematopoietic or non-hematopoietic compartments. Models of local or systemic 
bacterial infection can then be applied to these mice. 
Hepcidin-deficient mice have elevated systemic iron levels (Lesbordes-
Brion et al., 2006). The data in this Chapter examining immune cell function in 
the gut-draining lymph nodes of Hamp1-/- mice reveal a previously unrecognized 
role for hepcidin in immune cell homeostasis (Figure 39). Loss of hepcidin in vivo 
was associated with elevated pro-inflammatory cytokines IL-1β, IL-6 and 
enhanced Th1 and Th17 cell responses. Multiple factors could contribute to 
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these effects. Expression of hepcidin by the liver at steady state results in 
inhibition of iron release from macrophages and hepatocytes. Therefore, 
changes in intracellular iron levels by hepcidin may lead to altered immune cell 
homeostasis. Consistent with this idea, altered iron homeostasis is often 
associated with dysregulated systemic immune responses in vivo (Balouchi et 
al., 2014; Cunningham-Rundles et al., 2000; Ekiz et al., 2005). Although there is 
no known role for hepcidin itself in regulating immune responses, it is possible 
that it may directly control cytokine production by innate and adaptive immune 
cells through a novel pathway. Further investigation using gain and loss of 
function approaches such as iron supplementation and chelation is necessary to 
determine whether hepcidin-mediated iron homeostasis plays a role in 
modulating immune cell function at the steady state. 
Given the result that loss of hepcidin is associated with elevated pro-
inflammatory cytokine responses including IL-1β, IL-6 and IL-17A, which are 
critical members of innate and adaptive anti-bacterial immunity, one would 
predict that hepcidin-deficiency may actually confer protection against bacterial 
pathogens. However, there are multiple reports suggesting that hepcidin 
deficiency is associated with susceptibility to extracellular bacterial infections 
primarily due to an increased bioavailability of iron to invading pathogens (Arezes 
et al., 2015; Quenee et al., 2012). The relative contribution of immune versus iron 
defects in the context of antibacterial immunity is not well understood and should 
be the focus of investigation. 
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Hepcidin-deficient mice exhibit delayed recovery from DSS-induced 
intestinal inflammation. These data are consistent with a pathogenic role for the 
pro-inflammatory cytokines IL-1β and IL-6 in this model. Furthermore, intestinal 
inflammation is often associated with elevated Th17 cells (Weaver et al., 2013), 
which is a feature of Hamp1-/- mice at the steady state. It appears that loss of 
hepcidin does not influence disease outcome during DSS treatment but rather 
results in delayed recovery and tissue repair. As a result, mechanisms of repair 
in the host such as the production of IL-22, M2 macrophages and various growth 
factors should be measured in Hamp1-/- mice. 
This Chapter demonstrates that in addition to hepatocytes, DCs are a 
potent source of hepcidin in vitro. In vivo, loss of hepcidin was associated with 
elevated pro-inflammatory cytokine expression, elevated Th17 cell responses 
and delayed repair from DSS-induced intestinal injury (Figure 39). These results 
represent a key advance in our understanding of the interplay between iron 
homeostasis and immune cell function and may inform future therapeutic 
strategies for the treatment of anemia associated with chronic inflammation. 
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Figure 30. Lymphoid tissue-resident commensal bacteria alter te 
expression of genes associated with iron uptake, transport and storage in 
bone marrow-derived DCs. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. BMDCs were treated with PBS or colonized with Bordetella spp. and analyzed for 
gene expression by microarray on day 4. Numbers in colored legend represent Z scores. 
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Figure 31. Lymphoid tissue-resident commensal bacteria upregulate 
hepcidin in bone marrow-derived dendritic cells. 
 
 
 
 
 
 
 
 
 
 
Figure 31. (A) BMDCs were stimulated with Bordetella spp. (MOI 50), LPS (100 ng/ml), 
Pam3CSK4 (100 ng/ml) or CpG DNA (2 µg/ml) for 24 hours and Hamp1 expression was 
analyzed by qPCR. Statistics were performed using one-way ANOVA and Sidak’s multiple 
comparisons test. **** p < 0.0001. 
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Figure 32. Hepcidin regulates intracellular survival of lymphoid tissue-
resident commensal bacteria in bone marrow-derived dendritic cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Wild-type BMDCs were co-cultured with E. coli or Bordetella spp. for 2 hours and 
levels of live intracellular bacteria was assessed by culturing. Data are representative of two 
independent experiments. Statistics were performed using student’s t-test. l.o.d., limit of 
detection. ***, p < 0.001; **** p < 0.0001. 
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Figure 33. Loss of hepcidin in vivo is associated with altered expression 
pro-inflammatory cytokines in the mesenteric lymph node. 
 
 
Figure 33. Expression of Il1b, Il6, Il10 and Il12b were analyzed in the mesenteric lymph node of 
wild-type and Hamp1-/- mice by qPCR. Data are pooled from three independent experiments. 
Statistics were performed using student’s t-test. * p < 0.05; **, p < 0.01. 
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Figure 34. Loss of hepcidin in vivo is associated with elevated pro-
inflammatory CD4 T cell responses in the mesenteric lymph node. 
 
 
Figure 34. CD4 T cells in the mLN of wild-type and Hamp1-/- mice were analyzed for production 
of (A) IL-17A and IFNγ or (B) Foxp3 and RORγt following PMA and ionomycin stimulation. Cells 
in flow cytometry plots are gated as live, CD45+, CD3+, CD5+, CD4+. Data are representative of 
three independent experiments. Statistics were performed using student’s t-test. **, p < 0.01; ***, 
p < 0.001; ****, p < 0.0001. 
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Figure 35. Altered immune cell homeostasis in Hamp1-/- mice is not due to 
intestinal dysbiosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. 16S rDNA for different groups of bacteria were measured in the feces of wild-type and 
Hamp1-/- mice. Units on the y-axis represent bacterial-specific 16S rDNA relative to universal 16S 
rDNA. SFB, segmented filamentous bacteria. Data are pooled from three independent 
experiments. 
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Figure 36. Loss of hepcidin in vivo is associated with delayed recovery 
from DSS-induced intestinal injury. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Wild-type and Hamp1-/- were treated with 2.5% DSS for 7 days and then placed on 
regular drinking water. (A) Weight loss was measured throughout the course of the experiment 
and (B) colon pathology was assessed on day 12. Scale bar – 200 µm. Data are representative of 
two independent experiments. Statistics were performed using student’s t-test. **, p < 0.01. 
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Figure 37. Loss of hepcidin in vivo is associated with elevated frequencies 
of pro-inflammatory CD4 T cell responses during recovery from DSS-
induced intestinal injury. 
 
Figure 37. CD4 T cells in the (A) mLN and (B) colon of DSS-treated (day 12) wild-type and 
Hamp1-/- mice were analyzed for production of IL-17A and IFNγ following PMA and ionomycin 
stimulation. Cells in flow cytometry plots are gated as live, CD45+, Lineage+, CD4+. Lineage 
cocktail consists of CD3, CD5, CD8α, CD19, NK1.1. Data are representative of two independent 
experiments. Statistics were performed using student’s t-test. * p < 0.05; ***, p < 0.001. 
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Figure 38. Loss of hepcidin in vivo is associated with elevated frequencies 
of intestinal TNFα+ CD4 T cells and neutrophils during recovery from DSS-
induced intestinal injury. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. Frequencies of (A) TNFα-producing CD4 T cells (CD3+CD5+CD4+) and (B) neutrophils 
(CD3- CD5- CD11b+ Ly6G+) were analyzed in the colon of DSS-treated mice (day 12) following 
PMA and ionomycin stimulation. Data are representative of two independent experiments. 
Statistics were performed using student’s t-test. ***, p < 0.001. 
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Figure 39. Hepcidin and iron homeostasis regulate immune cell function. 
 
Figure 39. In wild-type mice, hepcidin controls systemic iron levels by inhibiting dietary iron intake 
and iron release from macrophages. Data from Chapter 4 suggest that hepcidin expression and 
the associated reduction in systemic iron levels act to suppress the production of the pro-
inflammatory cytokines IL-1β, IL-6 by innate immune cells and IL-17A, IFNγ and TNFα by CD4 T 
helper cells. Hepcidin may regulate the immune cell function independent of iron. In the mice that 
lack hepcidin, systemic iron levels increase due to uninhibited iron absorption and iron release 
from macrophages. Elevated systemic iron may lead to enhanced production of pro-inflammatory 
cytokines due to the release of reactive oxygen species (ROS). Elevated pro-inflammatory 
cytokine production in Hamp1-/- mice may be responsible for impaired tissue homeostasis 
following acute intestinal injury. 
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Chapter 5 
Summary, discussion and future directions 
 
5.1 Lymphoid tissue-resident commensal bacteria belong exclusively to the 
Proteobacteria phyla 
The mammalian intestine is colonized trillions of bacteria that belong 
predominantly to three phyla: Bacteroidetes, Firmicutes and Proteobacteria (Ley 
et al., 2005; Turnbaugh et al., 2006). Chapter 2 of this thesis identified that LRCs 
belong exclusively to the alpha- and beta-Proteobacteria classes. Collectively, 
Proteobacteria are classified as gram-negative bacteria that differ from their 
Bacteroidetes and Firmicutes counterparts in their requirement for oxygen. It is 
therefore possible that the metabolic requirements for Proteobacteria may be 
linked to their intestinal colonization pattern (Figure 40). In support of this, 
several reports identified that there is a unique spatial segregation of 
Proteobacteria versus Bacteroides and Firmicutes in the lumen of the intestine. 
For example, Proteobacteria are typically found in close proximity to the intestinal 
epithelial wall, where oxygen concentration is the highest compared to the center 
of the intestinal lumen (Albenberg et al., 2014; Flint et al., 2012; Ringel et al., 
2015; Yasuda et al., 2015). Therefore, sampling of luminal contents by 
phagocytic dendritic cells and macrophages that populate the intestinal lamina 
propria may be biased towards Proteobacteria members. Further investigation is 
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necessary to link the metabolic requirements of commensal bacteria 
communities with their distinct colonization pattern in the host intestine. 
 Proteobacteria are found not only in the mammalian GI tract but also in 
the environment. In fact, many of the strains predicted to be LRCs such as 
Bordetella, Achromobacter and Ochrobactrum are the causative agents for 
opportunistic infections in immunocompromised individuals (Hagiya et al., 2013; 
Melvin et al., 2014; Spilker et al., 2013). Specifically, strains of Bordetella and 
Achromobacter have been associated with respiratory tract infections in patients 
with cystic fibrosis (Melvin et al., 2014; Spilker et al., 2013). These data support 
the hypothesis that while LRCs inhabit mammals and maintain immune cell 
homeostasis in the presence of an intact and otherwise healthy immune system, 
their proximity to lymphocytes in immune cell-rich tissues can quickly alter their 
interactions with the host to become pathogenic. Therefore, future studies 
assessing the beneficial versus pathological functions of LRCs should do so in 
the context of healthy and diseased animals or patients to clearly identify host 
and microbial-specific factors that regulate a healthy host-LRC interaction. 
Proteobacteria levels frequently bloom during intestinal inflammation and 
have been associated with the pathogenesis of IBD (Melvin et al., 2014; Spilker 
et al., 2013). In light of the data in Chapter 3 that LRCs, which are 
Proteobacteria members, promote tissue protective properties in the context of 
acute intestinal injury, one may hypothesize that Proteobacteria that colonize a 
healthy GI tract are largely beneficial, especially those that colonize lymphoid 
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tissues. However, during loss of intestinal barrier function, the pathogenic 
members of Proteobacteria such as adherent invasive E. coli strains and 
Helicobacter pylori expand, become dominant members of the microbiota and 
contribute to disease. Therefore, understanding the role of LRCs in the context of 
other pathogenic Proteobacteria members is essential and should be a focus for 
future investigations. The biological implications of studying host-LRC 
interactions in the context of a replete microbiota will be described in the 
following section. 
 
5.2 Understanding LRC colonization in the context of a complex microbiota 
The results from Chapter 2 demonstrated that LRCs promote tissue-specific 
immune responses in gnotobiotic and antibiotic-treated mice where LRCs are the 
dominant bacterial population in the intestine. However, in nature, the 
composition of the gut microbiota reflects a complex community of 
microorganisms that have a diverse array of biological properties and functions. 
Further experimentation is necessary to investigate host-LRC interactions in the 
presence of a complex microbiota. However, this approach may be met with 
multiple challenges. Despite the fact that 16S rDNA for bacteria belonging to 
LRCs can be detected in the interior of intestinal-associated lymphoid tissues, 
live bacteria cannot be cultured from the gut-draining mesenteric lymph node of 
conventional mice that LRCs are predicted to colonize. This may either reflect the 
absence of live LRCs in conventional mice or that LRCs colonize lymphoid 
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tissues but maintain a dormant state and thus cannot be cultured using 
laboratory methods (Figure 41). The former hypothesis is supported by the 
finding that commensal bacteria, through a MYD88-dependent mechanism, 
inhibit trafficking of a specialized subset of CX3CR1-expressing phagocytic cells 
that sample the intestinal lumen (Diehl et al., 2013). Depletion of the gut 
microbiota using broad-spectrum antibiotics, similar to the experimental approach 
used to colonize antibiotic-treated mice with LRCs resulted in translocation of a 
non-virulent strain of Salmonella to the mLN and spleen. Developing a mouse 
model whereby live LRCs selectively colonize lymphoid tissues in the presence 
of other luminal and epithelial-associated commensal bacteria should take into 
account these factors.  
The infant GI tract is typically colonized with more Proteobacteria 
compared to the adult microbiota (Arrieta et al., 2014; Shin et al., 2015). One 
intriguing theory is that colonization with LRCs early in life may provide 
heightened immune cell maturation in lymphoid tissues. Over time, colonization 
by Bacteroidetes and Firmicutes may act to limit LRC colonization in lymphoid 
tissues to prevent pathologic inflammation. This hypothesis is supported by data 
demonstrating that early exposure to antibiotics may predispose humans to 
chronic inflammatory diseases such as allergic airway inflammation and obesity 
(Melvin et al., 2014; Spilker et al., 2013). Whether this reflects altered LRC 
colonization early in life is unknown and should be a subject of future 
investigation. 
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5.3 Commensal bacteria communities modulate tissue-specific immune cell 
function 
The gut microbiota that colonize the mammalian GI tract collectively influences 
the development and maturation of the host immune system (Hooper et al., 2012; 
Ivanov and Honda, 2012). Over last the decade, many reports have shown that 
commensal bacteria found in different sites of the intestine influence the local 
tissue immune environment. Data from Chapter 2 demonstrated that a novel 
class of commensal bacteria, lymphoid tissue-resident commensal bacteria 
(LRC), colonizes the interior of intestinal-associated lymphoid tissues such as the 
Peyer’s patch and mesenteric lymph node. Within these tissues, LRCs promote 
local ILC3 and Th17 cell responses but do not promote small intestine lamina 
propria responses despite detectable LRCs in the lumen. This is in contrast to 
the epithelial-associated commensal segmented filamentous bacteria (SFB), 
which promotes potent Th17 responses in both intestinal-associated lymphoid 
tissues and the small intestine lamina propria (Atarashi et al., 2015; Gaboriau-
Routhiau et al., 2009; Ivanov et al., 2009; Sano et al., 2015). Induction of tissue-
specific immune responses is therefore consistent with the colonization pattern of 
the commensal in the intestine, supporting the notion that commensal bacteria 
influence local immune responses. 
The data in Chapter 2 also revealed that LRCs promote IL-10 production 
by DCs and that IL-10 acts to limit Th17 cell responses in LRC-monocolonized 
mice. This may be an evolutionary conserved feature adopted by commensal 
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bacteria, especially LRCs, in order to limit the development of pathologic 
inflammation but simultaneously promote maturation of the host immune system. 
The finding that LRCs induce DC-derived IL-10 parallels the discovery that 
commensal populations promote regulatory T cell responses that limit pathologic 
inflammation (Atarashi et al., 2013; Atarashi et al., 2011; Round et al., 2011; 
Round and Mazmanian, 2010). The human commensal Bacteroides fragilis was 
demonstrated to colonize colonic crypts and is associated with elevated colonic 
Treg responses (Lee et al., 2013). Similarly, Gram-positive commensal bacteria 
from the class Clostridia colonize the lumen of the large intestine and also 
promote potent Treg responses in the underlying lamina propria (Atarashi et al., 
2013; Atarashi et al., 2011). Whether LRCs also promote Tregs has not been 
investigated and warrants future investigation. However, given the ability of LRCs 
to promote IL-6 and IL-23 in vitro, it is likely that LRCs can promote the subset of 
Tregs that express RORγt as this subset is induced by these cytokines 
(Ohnmacht et al., 2015; Sefik et al., 2015).  
LRCs may have the capacity to bypass intestinal barrier functions to 
colonize lymphoid tissues. Therefore, it can be hypothesized that LRCs have the 
capacity to modulate immune responses beyond the intestine. Indeed, 
neutralization of IL-22-producing ILC3 was demonstrated to result in systemic 
dissemination of LRCs, which resulted in elevated IL-6 and TNFα (Sonnenberg et 
al., 2012). Whether LRCs can modulate extra-intestinal immune responses, such 
as in secondary lymphoid tissues beyond the intestine, at the steady state 
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requires further experimentation. However, the cellular mechanisms by which 
LRCs promote tissue-specific immune effects appear to be direct communication 
between the bacteria and immune cells in the intestine (Figure 42). This is in 
contrast to the mechanism by which the epithelial-associated commensal SFB 
elicits Th17 cell responses. In the case of SFB, bacterial attachment is required 
for and leads to production of SAA1/2 by the epithelium that then induces a Th17 
cell response (Atarashi et al., 2015; Sano et al., 2015). Since LRCs do not elicit 
small intestine lamina propria Th17 cell responses, it is possible that LRCs do not 
have the ability to attach to intestinal cells and/or regulate their biology. LRCs 
may be able to access intestinal-associated lymphoid tissues exclusively by 
being recognized and captured by mononuclear phagocytes that sample 
intestinal lumen contents. Further research is necessary to decipher the precise 
molecular and cellular pathways by which LRCs promote tissue-specific immune 
responses. 
 
5.4 Beneficial properties of lymphoid tissue-resident commensal bacteria 
colonization in the host intestine 
Data from Chapter 3 demonstrated that IL-22 is required for the colonization of 
LRCs in the mesenteric lymph node. The mechanism of this pathway may 
involve the production of IL-22-dependent antimicrobial peptides such as the 
REG3 proteins, which limit the growth of both competing Gram-positive and 
Gram-negative commensals (Cash et al., 2006; Lehotzky et al., 2010; Mukherjee 
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et al., 2014; Sonnenberg et al., 2011; Vaishnava et al., 2011). In addition, 
Chapter 3 provided evidence that exogenous administration of IL-22 to LRC-
colonized mice enhanced LRC colonization. The mechanism of this pathway may 
also be due to upregulation of IL-22-dependent antimicrobial peptides and 
suppression of competing commensal bacteria. However, given the role of the 
iron-regulatory hormone hepcidin in intracellular survival of LRCs in vitro, 
administration of IL-22 may lead to hepcidin-mediated changes in iron 
homeostasis that favors LRC colonization in lymphoid tissues (Figure 43). 
IL-10 but not IL-22 produced by LRC-colonized DCs provide host tissue 
protection during acute intestinal injury. However, as IL-22 is known to have pro-
proliferative functions on inflamed and damaged tissues (Sonnenberg et al., 
2011), whether LRC-induced IL-22 plays a role for LRC-induced recovery from 
acute intestinal injury should be investigated. Therefore, the mechanism by which 
LRCs protect mice from DSS may involve the coordination of both IL-10 and IL-
22, where IL-10 provides protection from acute tissue damage whereas IL-22 
may provide signals that promote tissue homeostasis following acute injury. 
Given the role for IL-22 in enhancing LRC colonization in lymphoid tissues and 
the fact that IL-22 has tissue protective properties, it would also be interesting to 
test the hypothesis that IL-22-induced effects may be dependent on LRC 
colonization (Figure 43). 
IL-10 is induced by LRCs both in the gut-draining lymph node and colon 
lamina propria. In addition, IL-10 appears to function systemically as blockade of 
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IL-10-IL-10R interactions result in elevated serum IFNγ. The key question of 
whether lymphoid tissue colonization contributes to and is required for LRC-
mediated tissue protection is not well understood but requires further 
experimentation using approaches that selectively deplete lymphoid colonization 
by LRCs or mice that lack secondary lymphoid organs. It is likely that in the 
presence of a complex microbiota, LRCs adopt a more strict lymphoid 
colonization pattern whereas in antibiotic-treated mice, LRCs can exert its tissue 
protective effects through interactions with immune cells in both the lamina 
propria and lymphoid tissues. An alternative explanation for intestinal tissue-
protective effects by LRCs may lie in the ability of LRC-primed immune cells to 
traffic to the site of inflammation. Direct stimulation of immune cells in lymphoid 
tissues by LRCs may provide a more rapid response by directing tissue-
protective lymphocytes (such as those that produce IL-10 and IL-22) to the site of 
injury. Mice that lack gut homing molecules or trafficking machinery will be able 
to determine whether LRCs employ this pathway for host-protection. 
 
5.5 Analysis of commensal bacteria in lymphoid tissues during chronic 
inflammatory diseases  
Although the data from Chapter 3 suggest that LRC have beneficial tissue-
protective properties for the host, its unique colonization pattern in intestinal-
associated lymphoid tissues may result in pathologic inflammation when 
mechanisms of intestinal barrier function such as the production of mucus and 
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antimicrobial peptides are impaired. This is supported by translocation of LRCs 
and development of systemic inflammation in animals that are depleted of IL-22+ 
ILCs (Sonnenberg et al., 2012). In humans, this possibility was demonstrated in 
HIV patients that have enhanced systemic immune responses to commensal 
bacteria. One study showed that patients with HIV have elevated systemic IgG 
specific for the LRC, Alcaligenes (Tatro et al., 2014). Whether systemic immune 
responses to Alcaligenes is due to bacterial translocation from lymphoid tissues 
is unclear and warrants further investigation. However, these data highlight the 
dangers of commensal bacteria colonization in lymphoid tissues and thus more 
research is necessary to understand the mechanisms by which the host 
harnesses the beneficial but limits the pathological functions of LRCs. 
 
5.6 Interplay between commensal bacteria, the host immune system and 
iron homeostasis during health and disease 
Iron is an essential nutrient for all living organisms including mammals, 
pathogenic and commensal bacteria. Iron scavenging from the environment is 
therefore of critical importance to all organisms. In the mammals, mechanisms 
are present to sequester iron for host biological processes and limit their access 
from pathogenic microbes. Microbes on the other hand have also evolved 
molecular strategies to scavenge iron. Therefore, there is a constant “tug-of-war” 
between pathogenic microbes, commensal microbes and mammals for iron. In 
mammals, one pathway that acts to limit iron available to invading pathogens 
	   151 
involves the iron-regulatory hormone hepcidin (Arezes et al., 2015; Quenee et 
al., 2012). The receptor for hepcidin, ferroportin, is expressed on macrophages 
and hepatocytes and functions to export iron from these intracellular stores. 
Binding of hepcidin to ferroportin results in its degradation and therefore inhibition 
of iron release into the extracellular space (Cassat and Skaar, 2013; Ganz and 
Nemeth, 2015). Although there is substantial evidence for the role of hepcidin in 
limiting iron availability to pathogenic microbes, its role in regulating host-
commensal bacteria interactions is much less understood. Chapter 4 
demonstrated that loss of hepcidin in vivo was associated with elevated 
expression of proinflammatory cytokines. Upregulation of the cytokines such as 
IL-1β and IL-6 in hepcidin-deficient mice was associated with elevated Th17 cell 
responses. The mechanism by which loss of hepcidin in vivo leads to 
dysregulated cytokine production is unknown. However, one possibility is that 
generation of a pro-inflammatory immune environment is due to expansion of 
members of the microbiota in the presence of iron overload. As SFB is a potent 
inducer of intestinal and systemic Th17 cell responses (Gaboriau-Routhiau et al., 
2009; Ivanov et al., 2009), fecal 16S rDNA for SFB was measured and the 
results determined that SFB levels were comparable between hepcidin-deficient 
and wild-type mice. One experiment to interrogate whether other members of the 
microbiota may be responsible for elevated Th17 cells will involve the use of 
broad-spectrum antibiotics or derivation of hepcidin-deficient animals under 
germ-free conditions. Given the DC-intrinsic role for hepcidin in LRC colonization 
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in vitro, one may also speculate whether altered Th17 cell responses are due to 
dysregulated host-LRC interactions. One hypothesis is that in the absence of 
hepcidin, levels of intracellular LRCs are reduced leading to less production of IL-
10 and unrestrained Th17 cell responses. Experiments measuring the level of 
LRCs in lymphoid tissues of Hamp1-/- mice should address this possibility (Figure 
44).  
An alternative explanation for elevated pro-inflammatory immune 
responses in hepcidin-deficient mice is due to elevated production of reactive 
oxygen intermediates (Figure 39). Under the setting of iron overload, the redox 
potential of iron generates reactive oxygen species and hydroxyl radicals that 
can damage the lipids, DNA and protein of host tissues (Cassat and Skaar, 2013; 
Ganz and Nemeth, 2015). Production of ROS and cellular toxicity has been 
associated with increased expression of pro-inflammatory cytokines and 
increased Th17 cell responses (Naik and Dixit, 2011; Zhi et al., 2012). Future 
experiments using gain and loss of function approaches will be necessary to 
determine whether ROS levels are elevated in Hamp1-/- mice and are involved in 
hepcidin-mediated immune regulation. 
The animals used in Chapter 4 as controls for hepcidin-deficient mice 
were age and gender-matched mice that were purchased from Jackson 
Laboratories. These mice were cohoused with hepcidin-deficient mice for at least 
3 weeks prior to use to normalize their microbiota composition. Although the data 
suggest that loss of hepcidin leads to significant immune abnormalities, future 
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experiments should compare Hamp1-/- mice to littermate controls to rule out the 
possibility that the phenotypes observed are due to animals that have been 
reared under different environments. Experiments comparing littermates and 
knockout mice generated from breeding Hamp1+/- mice are currently on going to 
address this concern. 
 
5.7 Concluding remarks 
Commensal bacteria communities are essential inhabitants of the mammalian GI 
tract. These bacteria aid in nutrient metabolism, prevent pathogen colonization 
and promote maturation of the immune system. Our current understanding of 
commensal bacteria colonization suggest that they colonize at least three distinct 
anatomical sites: i) the intestinal lumen, ii) the intestinal epithelial surface and iii) 
intestinal-associated lymphoid tissues. Commensal bacteria from each of these 
three sites appear to interact with the host immune system in distinct manners. 
Luminal commensal bacteria are physically separated from the mucosal surface 
by antimicrobial peptides and mucus and influence host immune cell functions 
primarily through production of bacterial metabolites. Epithelial-associated 
commensal bacteria can colonize the surface of intestinal epithelial cells and 
interact with the host by altering the function of intestinal epithelial cells. Data in 
this thesis demonstrated that LRCs interact with the host via colonization of 
lymphoid tissues and activate innate and adaptive immune cells such as DCs, 
ILCs and CD4+ T cells. A comprehensive understanding of how these three 
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commensal populations interact and coordinate immune cell homeostasis is an 
area for future investigation and would involve the development of novel 
gnotobiotic mouse models. Understanding the contexts by which anatomically 
distinct commensal communities interact with the host may inform the 
development of immunologic- and bacterial-based therapeutic strategies for the 
treatment of chronic inflammatory diseases in people. 
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Figure 40. Spatial segregation of commensal bacteria in the intestine based 
on oxygen requirements. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40. Lymphoid tissue-resident commensal bacteria are predominantly Proteobacteria, 
while luminal commensals are predominantly Firmicutes or Bacteroidetes. Proteobacteria are 
typically gram-negative obligate aerobes or facultative anaerobes and thus differ from luminal 
microbes by their requirement for oxygen. Oxygen concentration is higher near the surface of the 
intestinal epithelium compared to the center of the lumen. Therefore, Proteobacteria may be 
preferentially localize to the intestinal epithelium and thus are more readily sampled by innate 
immune cells in the mucosa and poised to colonize intestinal-associated lymphoid tissues. 
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Figure 41. Understanding LRC colonization in the presence of a complex 
microbiota. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41. Chapters 2 and 3 demonstrate that LRCs regulate immune cell and tissue 
homeostasis in gnotobiotic or antibiotic mice where LRCs are the dominant bacterial species in 
the intestine. In order to fully define LRC colonization, future studies should investigate host-LRC 
interactions in the presence of a complex microbiota in conventional mice. Specifically, whether 
LRCs impact immune cell function in the same manner in gnotobiotic/antibiotic mice should be 
assessed. Previous work demonstrated that LRCs could not be cultured from intestinal-
associated lymphoid tissues of conventional mice. Future work should address whether this is 
due to lack of bacterial viability or LRCs adopting a dormant metabolic state. 
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Figure 42. Commensal bacterial communities regulate tissue-specific 
immune cell homeostasis through distinct pathways. 
 
Figure 42. Epithelial-associated, lymphoid tissue-resident and luminal commensals regulate 
immune cell homeostasis through distinct pathways. Epithelial-associated commensals such as 
SFB physically attach to epithelial cells and promote the production of serum amyloid A (SAA). 
SAA conditions dendritic cells (DCs) to drive Th17 cell responses. On the other hand, lymphoid 
tissue-resident commensals colonize the intracellular compartment of DCs and promote DC-
derived IL-1β, IL-6 and IL-23. These cytokines are likely responsible for LRC-induced Th17 and 
ILC3 responses. Luminal commensal bacteria regulate immune cell function likely through the 
production of bacterial-derived metabolites such as short chain fatty acids (SCFAs). SCFAs 
condition DCs and epithelial cells to promote regulatory T cell responses. 
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Figure 43. IL-22-induced hepcidin expression may promote LRC 
colonization and host-beneficial properties. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 43. Chapter 3 of this thesis demonstrated that IL-22 enhances host colonization by 
lymphoid tissue-resident commensal bacteria. Given the role of IL-22 in hepcidin expression and 
the role of hepcidin in LRC colonization, it is possible that IL-22-induced LRC colonization is 
dependent on hepcidin upregulation. IL-22 has potent tissue-protective effects by modulating anti-
microbial peptide production and tissue regeneration. Given the role of LRCs in host tissue 
protection during acute intestinal injury, future experiments should test whether IL-22 regulates 
tissue homeostasis in part through modulation of LRC colonization. 
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Figure 44. Regulation of immune cell homeostasis by hepcidin through 
modulation of lymphoid tissue-resident commensal bacteria colonization.   
 
Figure 44. Chapter 5 demonstrated that hepcidin promotes lymphoid tissue-resident commensal 
bacteria colonization in vitro and limits proinflammatory cytokine production by CD4 T helper 
cells. Given that LRCs promote IL-10, which restrains Th17 cell responses, hepcidin may regulate 
CD4 T cell responses through modulation of LRC colonization. In the presence of hepcidin, 
intracellular colonization by LRCs is favored and thus results in IL-10 production and suppression 
of CD4 T cell responses. In the absence of hepcidin, intracellular LRC colonization and IL-10 
production are impaired. As a result, proinflammatory cytokine production by CD4 T cells is 
uninhibited.  
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